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ABSTRACT 
 
Over the past few decades, RNA has emerged as much more than just an intermediary in 
biology’s central dogma.  RNA is now known to play a variety of catalytic, regulatory and 
defensive roles in living systems as demonstrated through the discoveries of ribozymes, 
riboswitches, microRNAs, small interfering RNAs, Piwi-interacting RNAs, small nuclear RNAs, 
clusters of regularly interspaced short palindromic repeat RNAs and long non-coding RNAs.  In 
contrast to the functional diversity of RNA, the chemical diversity has remained primarily 
limited to canonical polyribonucleotides, the 5’ cap on mRNAs in eukaryotes, modified 
nucleotides and 3’-aminoacylated tRNAs.  This disparity coupled with the powerful functional 
properties of small molecule-nucleic acid conjugates led us to speculate that novel small 
molecule-RNA conjugates existed in modern cells, either as evolutionary fossils or as RNAs 
whose functions are enabled by the small molecule moieties. 
We developed and applied a nuclease-based screen coupled with high-resolution liquid 
chromatography/mass spectrometry analysis to detect novel small molecule-RNA conjugates, 
broadly and sensitively.  We discovered NAD-linked RNA in two types of bacteria and further 
characterized the small molecule and RNA in Escherichia coli.  The NAD modification is found 
on the 5’ end of RNAs between 30 and 120 nucleotides long, and is surprisingly abundant at 
around 3,000 copies per cell.  Subsequent experiments to characterize further NAD-linked RNA 
have been undertaken, including sequencing the RNAs to which NAD is attached and elucidating 
the biological functions of the small molecule-RNA conjugate. 
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The development and application of a screen to detect novel nucleotide modifications that 
is independent of structure or biological context has the potential to increase our understanding 
of the functional and chemical diversity of RNA.  The discovery and biological characterization 
of NAD-linked RNA can provide new examples of RNA biology and offer insight into the RNA 
world. 
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Chapter One: 
 
The Functional and Chemical Diversity of Cellular RNA 
 
 2	  
1.1 The Functional Diversity of Cellular RNA 
 The functional roles of RNA have expanded tremendously over the past few decades to 
encompass much more than just the central dogma.  Ribozymes, riboswitches, microRNAs, 
small interfering RNAs, transcriptional regulators, and long non-coding RNAs are all examples 
of RNAs that are thought to play a broad range of catalytic, sensing, regulatory, or defensive 
roles in the cell.  These recently discovered novel RNAs have illuminated new mechanisms of 
important biological processes. 
 
1.1.1 RNA as Key Component of the Cellular Protein Translation Machinery 
The central dogma describes RNA’s cellular role as transferring genetic information from 
DNA into proteins.  Indeed, the first few discoveries of functional RNA concluded that it was 
involved with protein synthesis.  The ribosome was found to contain large RNAs, and abundant 
tRNA was necessary for cellular production of proteins.  mRNA provided the connection 
between DNA and proteins by acting as a substrate for the ribosome to template translation. 
By 1941, scientists learned that proteins were being synthesized in the presence of 
abundant RNAs.  Another two decades passed before the first functional role for RNA was 
discovered as an essential component to the translation machinery.  George Emil Palade 
observed a “small particulate component of the cytoplasm” in guinea pig liver cells using the 
electron microscope.  He saw molecules that were either free in the cytoplasm or bound to the 
cisternal membranes of the rough portion of the endoplasmic reticulum (ER).  Palade then 
moved to guinea pig pancreatic cells because they are very efficient protein producers and are 
packed with endoplasmic reticulum cirsternae studded with “microsomes” – what the “small 
particulates” were called. 
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Together with Philip Siekevitz, Palade isolated the pancreas from guinea pigs and 
fractionated the cellular components using a sucrose gradient.  They examined the different 
fractions using electron microscopy and established that microsomes arise by a peculiar 
fragmentation of the ER during which membrane vesicles with their attached particles pinch off 
from ER cisterna without leakage of the cisternal content.1  They used sodium deoxycholate to 
solubilize microsomal membranes, which allowed for the recovery of the attached particles by 
high-speed centrifugation.  The particles were shown to be rich in protein and RNA, and hence, 
were named RNPs for ribonucleoprotein particles.  Using biochemistry, cell fractionation 
procedures and electron microscopy, Palade and Siekevitz elucidated the function of the 
ribonucleoprotein particles as the exclusive site of protein synthesis and found that RNA is 
essential to the production of protein in the ribosome.1-5 
During this time, there was additional evidence accumulating that implicated a role for 
cellular RNA in protein synthesis.  The intermediate stages between amino acid activation and 
final incorporation into protein in the rat liver in vitro system offered unexplored regions in 
which to seek more direct evidence for a chemical association of RNA and amino acids.  By 
1953, Paul Zamecnik had succeeded in making the first cell-free system capable of carrying out 
net peptide bond formation through incorporation of 14C-amino acids.6  Using this system, he, 
Elizabeth Keller, and Mahlon Hoagland noticed that the RNA in a particular cytoplasmic fraction 
became labeled with 14C-amino acids and that the labeled RNA was subsequently able to transfer 
the amino acids to microsomal protein in the presence of GTP.7  From this, they concluded that 
the RNA, later named transfer RNA or tRNA, functions as an intermediate carrier of amino acids 
in protein synthesis. 
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However, a missing connection between the information carrier (DNA) and protein 
synthesis remained.  While there was still no direct evidence, scientists hypothesized that the 
order of nucleotides in DNA determined the order of amino acids in a protein.  Francis Crick 
proposed that RNA may act as the carrier of genetic information to direct protein synthesis.8  He 
predicted that an “adaptor” molecule that mediates between the genetic information in DNA and 
the functional amino acids of proteins. 
 Experimental evidence for mRNA came in 1961 when researchers cultured E. coli on 
media containing heavy carbon and nitrogen isotopes resulting in E. coli with labeled 
ribosomes.9  Then, the cells were infected with T2 bacteriophage and transferred to media 
containing 32P04 as the sole phosphorous source.  All of the RNA that was synthesized following 
the infection contained the 32P label and associated to the heavy ribosomes upon density gradient 
centrifugation.  During infection, there is vigorous synthesis of phage protein and DNA, but no 
change in bacterial RNA content.  Therefore, researchers concluded that there was an unstable 
RNA intermediate that was not rRNA or tRNA that allowed for protein synthesis.  This 
discovery revealed a fundamental mechanism for gene action: the coding sequences of genes are 
copied into short-lived RNAs that are transported out of the nucleus into the cytoplasm, where 
they are translated into proteins.  Because such RNAs carry information from genes in the 
nucleus to the cytoplasm, they are designated as messenger RNAs. 
During protein synthesis, tRNAs deliver amino acids to the ribosome, where the 
ribonucleoprotein complex links amino acids together to form proteins.  mRNA provides the 
template for tRNA to base pair with in order to translate nucleic acids into amino acids.  tRNA, 
rRNA and mRNA form the foundation of biology’s central dogma where genetic information 
from DNA is converted into functional proteins. 
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1.1.2 RNA as Key Component of the Complex for Protein Membrane Integration 
Signal recognition particle (SRP) RNA was first detected in avian and murine oncogenic 
RNA virus particles.10  Researchers purified the virus and extracted total RNA.  After 
chromatography of the nucleic acids, they found a 7S RNA that had not previously been 
described.  Subsequently, SRP RNA was found to be a stable component of uninfected HeLa 
cells where it associated with membrane and polysome fractions.11,12  In 1980, cell biologists 
purified from canine pancreas an 11S "signal recognition protein" (fortuitously also abbreviated 
"SRP") which promoted the translocation of secretory proteins across the membrane of the ER.13  
It was then discovered that SRP contained an RNA component.14 
SRP is an abundant, cytosolic, universally conserved ribonucleoprotein that recognizes 
and targets specific proteins to the endoplasmic reticulum in eukaryotes and the plasma 
membrane in prokaryotes.  The function of SRP was discovered by the study of processed and 
unprocessed immunoglobulin light chains,15 which were produced in cell-free and reconstituted 
systems.  After introducing radioactive amino acids into the biological systems during protein 
synthesis, researchers observed two different molecular weight products.  Digestion of the 
products showed that the N-terminus was altered, so they proposed that the light chains are 
initially synthesized as a larger precursor of slightly higher molecular weight and subsequently 
converted into the authentic product. 
The SRP binds the N-terminal hydrophobic signal sequences in newly synthesized 
proteins in eukaryotes when they emerge from the ribosome.  This interaction leads to the 
slowing of protein synthesis known as "elongation arrest," a conserved function of SRP that 
facilitates the coupling of the protein translation and the protein translocation processes.  SRP 
then targets this entire complex (the ribosome-nascent chain complex) to the protein-conducting 
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channel in the ER membrane, which occurs via the interaction and docking of SRP with its 
cognate SRP receptor that is located in close proximity to the translocon. 
 
1.1.3 RNA as Key Component of Ribosome Rescue 
Transfer-messenger RNA (tmRNA, also known as 10Sa RNA and SsrA) is a bacterial 
RNA molecule with dual tRNA-like and mRNA-like properties.16  The tmRNA forms a 
ribonucleoprotein complex (tmRNP) together with Small Protein B (SmpB), Elongation Factor 
Tu (EF-Tu), and ribosomal protein S1.  In trans-translation, tmRNA and its associated proteins 
bind to bacterial ribosomes that have stalled in the middle of protein biosynthesis.  The tmRNA 
recycles the stalled ribosome, adds a proteolysis-inducing tag to the unfinished polypeptide, and 
facilitates the degradation of the aberrant mRNA.  In the majority of bacteria these functions are 
carried out by standard one-piece tmRNA.  In other bacterial species, a permuted ssrA gene 
produces a two-piece tmRNA in which two separate RNA chains are joined by base-pairing. 
tmRNA was first designated 10Sa RNA after a mixed “10S” electrophoretic fraction of E. 
coli RNA was further resolved into tmRNA and the similarly-sized RNase P RNA (10Sb).17  The 
presence of pseudouridine in the mixed 10S RNA hinted that tmRNA has modified bases found 
also in tRNA.  The similarity at the 3' end of tmRNA to the T stem-loop of tRNA was first 
recognized upon sequencing ssrA from M. tuberculosis.18  Subsequent sequence comparison 
revealed the full tRNA-like domain formed by the 5’ and 3’ ends of tmRNA, including the 
acceptor stem with elements like those in alanine tRNA that promote its aminoacylation by 
alanine-tRNA ligase.19  It also revealed differences from tRNA: the anticodon arm is missing in 
tmRNA, and the D arm region is a loop without base pairs. 
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1.1.4 RNA as Regulator of Cellular Gene Expression  
 Gene regulation is the process where cells and viruses regulate the way that information 
in genes is turned into gene products, which are typically proteins.  RNAs in all kingdoms of life 
have been discovered and characterized to participate in gene regulation.  The number of 
noncoding RNA genes, ones that produce functional RNA rather than encode for protein 
translation, has greatly increased over the past few decades.  The clusters of regularly interspaced 
short palindromic repeat (CRISPR) RNA is thought to confer a defensive mechanism to its cells 
and serve as a “genetic memory” of the parasites they have encountered.  Long noncoding RNA 
has a variety of functions, including imprinting and dosage compensation.  Riboswitches bind 
small molecule metabolites to regulate it’s own transcription and translation.  Small RNAs such 
as antisense RNA, microRNA, piwi-interacting RNA and small interfering RNA function as 
guide RNAs within the broad phenomenon known as RNA silencing.  All of these discoveries 
demonstrate that RNAs are quite diverse in their regulatory roles.  
RNA interference (RNAi) is the induction of sequence-specific gene silencing by double-
stranded RNA (dsRNA) found exclusively in eukaryotes.  In the laboratory, RNAi is a powerful 
tool that makes gene inactivation possible in organisms that were not amenable to genetic 
analysis before.  In nature, RNAi may both play an important biological role in protecting the 
genome against instabilities caused by transposons and repetitive sequences and be an ancient 
antiviral response/protection mechanism in both animals and plants.20,21  Recent genetic analyses 
provide evidence that RNAi may also have integral functions in the regulation of endogenous 
genes.22 
The RNAi process of dsRNAi-directed mRNA cleavage begins when Dicer or a Dicer 
homolog cleaves the dsRNA to 21-23 nucleotide long fragments.23-26  The resulting small 
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interfering (siRNA) fragments are bound by RNAi-specific enzymes and are incorporated into a 
distinct RNA-induced silencing complex (RISC) that targets mRNA for degradation.  The 
complex cleaves the mRNA in the center of the region recognized by the siRNA.   
In addition to siRNAs, microRNAs (miRNAs) are another type of small RNA that 
participates in RNAi.  The endogenous ∼23 nt RNAs play important gene-regulatory roles in 
animals and plants by pairing to the mRNAs of protein-coding genes to direct their 
posttranscriptional repression.27  miRNAs were discovered when two small regulatory RNAs, 
lin-4 and let-7, were found to control the timing of larval development in the worm 
Caenorhabditis elegans.28,29  In 1993, researchers found that LIN-14 protein abundance was 
regulated by a short RNA product encoded by the lin-4 gene.  A 61-nucleotide precursor from 
the lin-4 gene matured to a 22-nucleotide RNA that contained sequences partially 
complementary to multiple sequences in the 3’ UTR of the lin-14 mRNA.  This complementarity 
was both necessary and sufficient to inhibit the translation of the lin-14 mRNA into the LIN-14 
protein.  Only in 2000 was a second RNA characterized: let-7, which repressed lin-41, lin-14, 
lin-28, lin-42, and daf-12 expression during developmental stage transitions in C. elegans.  let-7 
was soon found to be conserved in many species, including mammals, indicating the existence of 
a wider phenomenon.30,31  miRNAs have since been found in plants, green algae, viruses, and 
more deeply branching animals. 
miRNAs show very different characteristics between plants and metazoans.  In plants, 
repressions on transcriptional level usually require perfect or near perfect target match, while 
mismatched target can lead to gene silence on translational level.32  In metazoans, on the other 
hand, miRNA complementarity typically encompasses the 5' bases 2-7 of the microRNA, and 
one miRNA can target many different sites on the same mRNA or on many different mRNAs.27  
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Another difference is the location of target sites on mRNAs.  In metazoans, the miRNA target 
sites are in the 3'-untranslated region of the mRNA, whereas in plants, targets are more often in 
the coding region itself.  While the detailed mechanisms are slightly different in metazoans and 
plants, miRNAs base pair with mRNAs in both to direct posttranscriptional repression. 
Piwi-interacting RNA (piRNA) are distinct from miRNA in size (26–31 nt rather than 
21–24 nt), lack of sequence conservation, and increased complexity.  However, like other small 
RNAs, piRNAs are thought to be involved in gene silencing, specifically the silencing of 
transposons since the majority of piRNas are antisense to transposon sequences.33  piRNAs form 
RNA-protein complexes that have been linked to both epigenetic and post-transcriptional gene 
silencing of retrotransposons and other genetic elements in germ line cells, particularly those in 
spermatogenesis.34  They are the largest class of small non-coding RNA molecules that is 
expressed in animal cells.33 
Like the other small RNAs, antisense RNA act by sequence complementarity to target 
RNAs (sense RNAs), which are primarily mRNAs encoding proteins of important functions.  
These small, diffusible and highly structured RNAs are transcribed from a promoter located on 
the opposite strand of the same DNA molecule, and are, therefore, fully complementary to their 
target RNAs.  However, over the past years, a number of antisense RNAs were detected that are 
encoded in trans, having only partial complementarity to their target RNA and having more than 
one target.  Antisense RNA control functions in all three kingdoms of life, but the majority of 
examples are known from bacteria.35 
In contrast with short RNAs, long non-coding RNA (long ncRNAs or lncRNA) are in 
general considered as non-protein coding transcripts longer than 200 nucleotides that also 
function to orchestrate genetic regulatory outputs.  Genetic studies identified a few lncRNA 
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genes involved in imprinting and other cellular processes, where the human X-(inactive)-specific 
transcript RNA is a canonical example.36  This 17-kb lncRNA has a key role in dosage 
compensation and X-chromosome inactivation.  Long ncRNAs have also been shown to 
modulate the function of transcription factors by several different mechanisms, including 
functioning themselves as co-regulators, modifying transcription factor activity, or regulating the 
association and activity of co-regulators.  However, many of the functional roles for lncRNAs 
still remain mostly elusive. 
 
1.1.5 RNA as Key Component of the Bacterial Defense System  
The clusters of regularly interspaced short palindromic repeat (CRISPR)-based defense 
system protects many bacteria and archaea against invading conjugative plasmids, transposable 
elements, and viruses.37  The cells acquire resistance by incorporating short stretches of invading 
DNA sequences in genomic CRISPR loci.  These integrated sequences, ranging in size from 24 
to 48 base pairs, are thought to function as a genetic memory that prevents the host from being 
infected by viruses containing this recognition sequence.  A number of CRISPR-associated (cas) 
genes has been reported to be essential for the phage-resistant phenotype.37  However, the 
molecular mechanism of this adaptive and inheritable defense system in prokaryotes has 
remained unknown. 
 
1.1.6 RNA as Cellular Metabolite Sensor  
Traditionally, proteins were the only macromolecules that had the ability to monitor the 
metabolic status of the cell.  However, in 2002, researchers presented the first comprehensive 
proofs of multiple riboswitch classes, including protein-free binding assays that established 
 11	  
metabolite-binding riboswitches as a new mechanism of gene regulation.38-41  Riboswitches 
reside in the leader sequences of numerous bacterial operons and control both transcription and 
translation by adopting alternative RNA structures, which can induce or prevent the formation of 
intrinsic terminators or ribosome binding site sequesters.  Thus, depending on the configuration 
of the leader transcript, the same riboswitch can either be a repressor or an activator of a cognate 
gene.42  Therefore, mRNAs that contain a riboswitch regulates its own activity levels in response 
to the concentration of its target molecule. 
Prior to the discovery of riboswitches, accumulating evidence suggested that the mRNA 
might be involved in binding metabolites directly to effect their own regulation.  There were 
conserved RNA secondary structures often found in the UTRs of the relevant genes and the 
success of procedures to create artificial aptamers.43-46  Structurally diverse metabolites have 
since been discovered to bind to the leader sequences of numerous metabolic genes in both 
Gram-positive and Gram-negative bacteria.42  Interestingly, riboswitches in Gram-negative 
bacteria tend to function via modulation of translation initiation, whereas in Gram-positive 
bacteria they predominantly function via transcription termination.42 
The known riboswitches are highly conserved among bacteria, which argues for their 
ancient origin.42  They may represent molecular fossils, a holdover from the RNA world.  By 
contrast, since riboswitches are the fastest reacting regulatory systems because no intermediate 
factors are involved, various organisms could develop their own “modern” riboswitches for other 
processes associated with RNA.42  
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1.1.7 RNA as Biological Catalyst  
Before the discovery of ribozymes, proteins were the only known biological catalysts.  
Researchers had hypothesized that RNA could act as a catalyst due to it’s ability to form 
complex secondary structures.47  In 1982, Tetrahymena was found to contain a self-splicing 
RNA without any associated protein.48  The following year, catalytic activity was discovered in 
the RNA component of ribonuclease (RNase) P, providing the first example of a multiple-
turnover enzyme using RNA-based catalysis.49  Since then, other investigators have discovered 
additional examples of self-cleaving RNA or catalytic RNA molecules.  The term ribozyme was 
developed for the general concept of an RNA molecule with enzyme-like activity. 
RNA-based catalysts have similarities to their protein enzyme counterparts.  Ribozymes 
can have substantial rate enhancements, comparing the rate constant for the self-cleaving 
hepatitis delta virus (HDV) of 102 - 104 s-1 with the maximal cleavage rate of RNase A of 1.4 x 
103 s-1 at 25 °C.50  Like proteins, ribozymes can also use cofactors such as imidazole during 
catalysis.51,52  Furthermore, molecular structures have revealed that ribozymes and protein 
catalysts can fold into specific three-dimensional shapes that can have deep grooves and solvent-
inaccessible active sites.  These structures facilitate catalysis by orienting structures adjacent to 
catalytic groups and metal ions.50 
The functional diversity of RNA has greatly increased over the past few decades.  RNA 
has been found to participate in a variety of unexpected cellular roles such as catalysis, 
metabolite sensing, gene regulation and defense against foreign nucleic acids, in addition to its 
participation in protein synthesis.  The versatility of RNA is surprising, especially given the 
limited chemical diversity of these nucleic acids. 
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1.2 The Chemical Diversity of Cellular RNA 
 In the six decades since their initial discovery,53 researchers have identified nearly 100 
modified nucleosides, spanning the three kingdoms of life almost all in RNA.54-56  The location 
and distribution of the chemical modifications vary greatly between different RNA molecules, 
organelles and organisms.  While modifying enzymes and biosynthetic pathways have been 
identified for some of the nucleosides, the biochemical and physiological functions of many of 
these modifications are still mostly unknown. 
When modified RNAs were first discovered, researchers assumed that the RNA 
polymerase incorporated the modified nucleotide during transcription.57  A few years later, 
researchers showed that methylation occurred on the polynucleotide level following primary 
transcript synthesis.  In fact, all RNA modifications in E. coli with the exception of queuosine, 
are formed after transcription.  The number of RNA modification enzymes is much higher than 
the number of RNA modifications present in E. coli.55  One nucleoside modification often 
requires the action of several modification enzymes.  Even proteins that are not directly 
interacting with RNA may be considered an RNA modification enzyme since they may 
synthesize a substrate that another RNA modification enzyme may require for activity. 
Overall, RNA modifications may reinforce hydrogen bonds (such as pseudouridine in 
RNA double helices), improve base stacking (like m5s2U in the TΨC loop and hypermodified 
purines in the anticodon loop), alter the flexibility of the nucleoside (like 2’-O-methyl 
derivatives) or promote additional binding sites for metal ions (mostly Mg2+).57  As a result, fully 
modified RNA is more rigid and more resistant to thermal denaturation than unmodified RNA 
transcript.  However, unmodified RNAs show little change in phenotype when compared with 
modified RNAs. 
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1.2.1 Chemical Modifications on tRNA 
Of all the RNAs in the cell, tRNAs contain the highest frequency of known 
modifications.  ~10 % of bacterial tRNA are modified nucleosides, whereas up to 25 % of the 
nucleosides in tRNA from eukaryotes are modified.57  There are common modifications that 
belong to bacteria, eukaryotes and archaea, some of which are even present in similar positions.  
Therefore, unless there was convergent evolution, this pattern suggests that there may be a 
common origin for some of these modified nucleosides.  These altered nucleosides may enhance 
tRNA’s ability to interact with diverse molecules such as aminoacyl–tRNA ligases, elongation 
factors and ribosomal proteins as well as mRNA and rRNA. 
 In tRNA, the wobble position and 3’ to the anticodon bases are most frequently modified, 
and there is a large variety of the modification at those two positions.54  This suggests that their 
presence is important for the anticodon-codon interaction.  There is evidence that 5-
methyluridine and queosine derivatives prevent missense errors within a codon box.57  The 
presence of some modified nucleosides is important for the recognition of aminoacyl-tRNAs so 
appropriate charging of a tRNA and translation efficient may be dependent on these 
modifications.  The modified nucleosides may also increase translational fidelity.  For example, 
1-methylguanosine prevents tRNA from frameshifting, and lack of it reduces the growth rate 
considerably in yeast and is essential in Streptococcus pneumoniae.57  The high frequency and 
diversity of chemical modifications in the tRNA anticodon loop may also affect tRNA structure 
to optimize interactions with mRNA, rRNA and translational proteins. 
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1.2.2 Chemical Modifications on rRNA 
While the modifications in tRNA are chemically diverse, rRNA nucleosides are modified 
in only a few ways.  The modifications are confined to isomerization of U to pseudouridine (Ψ), 
addition of H across the 5,6 double bond of U to form dihydrouridine (hU), and addition of 
methyl groups to the purine and pyrimidine rings and to the 2'-hydroxyl of ribose.  Similar to 
tRNA, the distribution of modified nucleosides is not random in rRNA either.58  Three-
dimensional maps of the modified nucleotides in the ribosomes of E. coli and yeast reveal that 
most (∼95 % in E. coli and 60 % in yeast) occur in functionally important and conserved regions.  
These include the peptidyl transferase center, the A, P and E sites of tRNA- and mRNA binding, 
the polypeptide exit tunnel, and interacting faces of subunits.  For example, domain V in the 
large subunit has long been linked to peptidyl-transferase activity and tRNA binding, and is 
especially rich in modifications.59  The correlations suggest that many ribosome functions benefit 
from nucleotide modification including having altered steric properties, different hydrogen-
bonding potential, enhancement of local base stacking and increased structural rigidity for both 
single- and double-stranded regions.58  Notably, modifications are essentially absent from areas 
dominated by ribosomal proteins: the external surfaces and periphery of the interface regions, 
which suggest that most RNA-protein interactions are not affected directly by modification.60-62 
 
1.2.3 Chemical Modifications on mRNA 
 mRNAs in eukaryotes have a 5’ cap that consists of a 7-methylguanylate (m7G) that 
provides significant resistance to 5’ exonucleases, facilitates transport from the nuclease, 
enhances translation efficiency and increases mRNA splicing efficiency.  Further modifications 
include the possible methylation of the 2’-hydroxyl groups of the first two ribose sugars of the 5’ 
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end of the mRNA.  The capping process is essential to creating mature mRNAs that can then 
undergo translation. 
The highly regulated capping process begins by RNA terminal phosphatase removing the 
gamma phosphate on the 5’ end of mRNA.  Then, guanylyl transferase cleaves a pyrophosphate 
off GTP and adds GMP to the terminal phosphates resulting in a 5’ to 5’ triphosphate linkage.  
Finally, a methyl transferase adds a methyl group to the 7’-nitrogen of guanine.  Capping is 
tightly controlled and necessary for creating mRNAs that will be translated into proteins. 
 
1.2.4 Functional Roles for RNA Chemical Modifications  
The level of RNA modification is sensitive to various metabolic stress conditions and 
developmental stages.58  Growth conditions and the environment can affect tRNA modifications 
both quantitatively and qualitatively, e.g. bacteria growing under starvation conditions for certain 
amino acids or iron leads to under-modification of tRNA.63  The link between the synthesis of 
modified nucleosides in tRNA and metabolism has been suggested to be a regulatory device and 
tRNA modification as a "biological sensor." 
However, the functional roles of modifications have been difficult to determine because 
unmodified RNA has subtle (if any) phenotype changes.  For most tRNAs, unmodified versions 
have almost the same efficiency as the modified RNAs in accepting amino acids.  However, a 
few unmodified tRNAs are severely affected in the aminoacylation reaction since these tRNAs 
lack modified nucleosides in the wobble position or 3’ to the anticodon that is necessary for the 
cognate aminoacyl-ligase recognition.64  While most completely unmodified tRNAs are able to 
accept amino acids in vitro, under certain conditions such tRNAs show considerable changed 
kinetics of aminoacylation because unmodified tRNA does not adopt the native conformation.  
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Therefore, modifications change the tRNA structure in a way that may influence the efficiency 
of the aminoacylation reaction and counteract mischarging.  But there are examples, such as the 
unmodified E. coli tRNAs specific for methionine and valine, that are not mischarged suggesting 
that modified nucleosides are not always fidelity markers for tRNA identity.  Generally, 
modified nucleosides improve the performance of the tRNA in the various processes of cellular 
metabolism. 
While taken individually, modified nucleosides are rarely indispensable and can be 
absent in functional tRNA, but their complete absence may be deleterious.  In E. coli, no 
modified nucleosides were shown to be essential for viability, but the lack of certain modifying 
enzymes can lead to lethality.65  In S. cerevisiae, three tRNA modifying enzymes 
(Gcd10p/Gcd14p, Tad2p/Tad3p and Thg1p) that modify m1A58,66  I3467 and tRNAHis G-1 
(guanine nucleotide to the 5'-end of tRNAHis)68 are known to be essential.  Deficiency of 
modified nucleosides can, therefore, lead to reduced translation efficiency and increased 
translation errors, which will affect gene expression regulation and cell metabolism.64 
The possibility exists that certain modified nucleosides are important in other cellular 
processes in which tRNA molecules are involved (such as regulation of gene expression, links to 
other metabolic processes like synthesis of porphyrines or cell wall, cell differentiation, 
development of certain diseases like cancer or certain forms of auto-immunity).57  The structural 
and thermodynamic effects of nucleoside modifications depend on the structural context, and can 
extend beyond the site of modification. 
Although the regulatory effect of hypomodification may occur at several places in an 
mRNA (presence of specific structures, sequences prone to frameshifting, etc.), the 5' end seems 
to be especially sensitive to small translational aberrations.  Ribosomes stalled early on an 
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mRNA due to modification deficiency will indirectly influence translation initiation of that 
mRNA, resulting in a lower degree of translation.  There is a preferential usage of rare codons 
within the 25 first codons of mRNAs.58  This codon bias early in the mRNA is critical for the 
efficiency of translation.  Therefore, some mRNAs may have sites in the beginning that are 
sensitive to the modification status of the tRNA reading these sites. 
 
1.3 The Discovery of Modified Nucleosides 
 Before 1948, nucleic acids were thought to contain only the four canonical bases, without 
any modification.  Within the next decade, 5’-methylcytosine was found in DNA hydrosylates69 
and what later became called pseudouridine was characterized as the fifth RNA base.70  The 
development of methods for purifying and sequencing different types of RNAs from diverse 
organisms in the three domains of life have led to the identification of more than a hundred 
modified nucleosides.71 
 Traditionally, novel modified nucleosides are discovered by digesting isolated nucleic 
acids with nuclease followed by purifying and characterizing the fractions by chromatography.71  
Indeed, the first modified nucleosides were found using this method.69,70  In general, researchers 
subjected RNA to nuclease digestion and phosphatase followed by labeling to incorporate a 
radiolabel into the mononucleotides or short oligonucleotides.  They subjected the digested and 
labeled nucleotides to thin-layer chromatography (TLC), purified the spots and characterized the 
products.  Comparison with authentic standards confirmed their identities. 
 As analytical methods advanced, high-performance liquid chromatography (HPLC) and 
mass spectrometry replaced TLC for the identification of novel nucleoside modifications.72-74  
The resolution achieved with the liquid chromatography system coupled with the high sensitivity 
 19	  
of the mass spectrometer is optimal for the discovery and characterization of modified 
nucleosides.  Furthermore, experiments such as tandem MS and collision induced dissociation in 
the LC/MS system allows for more facile structural elucidation.  The procedure for analyzing 
digested nucleic acids is also streamlined due to the removal of the radiolabeling step.  Thus 
currently, electrospray ionization (ESI) LC/MS is the method of choice to characterize modified 
nucleosides. 
 While the technology has improved for detecting and characterizing novel modifications 
on nucleic acids, many of the studies are targeted toward specific classes of RNA.  For example, 
researchers have isolated tRNAs, rRNA, mRNAs as well as sRNAs to digest and investigate 
potential nucleoside modifications.  Therefore, an unbiased screening approach that probes the 
modified nucleosides from total RNA would present a more complete picture of the chemical 
diversity of cellular RNA.  Developments in LC/MS would aid in this method to sensitively and 
accurately detect novel nucleoside modifications that are present in cellular RNA. 
 
1.4 The Functional Capacity of Small Molecule-Nucleic Acid Conjugates 
 The RNA world hypothesis proposes that at the origin of life, the first self-replicating 
system contained only RNA.75  During this time, RNA would serve as both the genetic material 
and the principal cellular enzyme.  Due to the discovery of catalytic RNAs, Gilbert postulated 
that RNA may have been capable of catalyzing the synthesis of themselves.75  Based on the 
mechanism of the self-splicing intron, RNAs may have been able to splice itself out of and back 
into an appropriate nucleotide sequence.  Thus, in an RNA world, RNAs may use this method for 
recombination and introduction of mutations against a background of replicating RNA 
molecules.  RNA is ideally suited for this because it can carry replicable genetic information 
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while having the flexibility of assuming a wide variety of secondary and tertiary structures.  The 
RNA can acquire additional enzymatic functions by using metal ions, amino acids and small 
molecule cofactors such as nicotinamide adenine dinucleotide and flavin mononucleotide.75 
 To form the lipid bilayer of the cell membrane in an RNA world, there needed to be a 
mechanism to make carbon-carbon bonds for the oligomerization process leading to polyketide 
and polyprenoid structures.76  Tauer and colleagues have also hypothesized that RNA 
participated in aldol, Claisen and transmethylation reactions in addition to porphyrin 
biosynthesis.77  Scott proposed an RNA-templated mechanism for the synthesis of polyketide, 
and by extension, fatty acid and polyprenoid biosynthesis.  Hybridization of misacylated tRNA 
with acetyl and malonyl equivalents to a short RNA would allow the 3’-esters to engage in the 
necessary Claisen chemistry of polyketide synthesis.  If the monomeric nucleosides were 
charged with 3’-phosphorylated RNA, the orientation would allow the formation of terpenoids, 
thereby providing a second avenue for production of lipids in the primitive organism.76 
 Indeed, small molecules linked to nucleic acids have demonstrated a wide range of 
chemistries in vitro.  Specifically, functionalized nucleic acids can participate in a variety of 
chemical reactions between duplex DNA-linked reagents in DNA-templated organic synthesis 
(DTS).78-80  The Watson-Crick base pairing of DNA-linked reagents significantly increases the 
effective molarity of reactivity while maintaining partner specificity to allow numerous DTS 
reactions in a single solution.  DTS has been used to synthesize small molecules,78,80,81 discover 
new reactions82,83 and generate macrocycle libraries.84  Given the general in vitro utility of DNA-
linked small molecules, cellular systems may employ functionalized nucleic acids. 
Primitive organisms may have used a RNA-based mechanism for carbon-carbon bond 
formation that led to lipids and porphyrins.76  Nucleic acid-linked small molecules may be a 
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remnant from the hypothesized RNA world, where RNA catalyzed their own replication.75  As in 
DTS, linked reagents may have broadened the scope of RNA mediated catalysis and improve the 
fidelity of information transfer, leading to evolutionary preservation.  An investigation of small 
molecule-RNA conjugates in extant organisms may yield insights into the RNA world and the 
earliest biochemistry. 
 
1.5 Thesis Overview  
The known chemical diversity of natural RNA has remained limited despite a growing 
number of elucidated biological roles for RNA.  Canonical polyribonucleotides, 3’-
aminoacylated tRNAs,7 modified nucleobases,85 and (in eukaryotes) 5’-capped mRNAs86,87 are 
the major known chemical components of natural RNA.  In contrast, the more recent discovery 
of ribozymes,50 riboswitches,88 microRNAs (miRNAs),89 small interfering RNAs (siRNAs),90 
Piwi-interacting RNAs (piRNAs),91 small nuclear RNAs (snRNAs),92 CRISPR sRNAs,93 RNA 
transcriptional regulators,94 and long non-coding RNAs95,96 have greatly expanded the known 
functional roles of natural RNA beyond those described in the central dogma.  As a result of 
these discoveries, RNA is now known to play a variety of catalytic, regulatory, and defensive 
roles in living systems. 
Researchers have previously speculated that early biotic systems carried out biochemical 
reactions using small molecule-RNA conjugates, perhaps in the form of RNA-templated 
chemistries.77,97-102  Recent studies involving artificial DNA-templated chemistries79,84,103,104 also 
highlight the unusual functional capabilities of small molecule-nucleic acid conjugates.  These 
observations collectively led us to speculate that small molecule-RNA conjugates beyond those 
previously described may exist in modern cells.105 
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By exploiting the improved resolution of ultra-performance liquid chromatography 
(UPLC) and the increased sensitivity of current MS methods, we can detect and characterize 
small molecule-RNA conjugates that are present as low as 30 copies per bacterial cell, 
representing a ~200-fold increase in sensitivity over previously described methods.  
Furthermore, the known examples of modified nucleosides have predominantly been discovered 
through serendipity or through a focused, hypothesis-driven approach.  In principle, a broad, 
unbiased analysis of all small molecule-RNA conjugates in a cell may reveal a much larger set of 
such species.  We are studying the entire set of nucleic acids that are present in a cell, rather than 
isolating a specific class or type of RNAs such as tRNA or rRNA.  We also do not require a 
specific type of chemical linkage or reactivity for detection. 
We have developed and implemented a method that in principle enables the detection of 
any small molecule-RNA conjugate regardless of its chemical structure.  Our method uses 
enzymatic digestion of total cellular RNA to mononucleotides and comparative high-resolution 
liquid chromatography and mass spectrometry (LC/MS) coupled with computational analysis to 
identify non-canonical masses that are putatively linked to cellular RNA.  MS/MS fragmentation, 
isotope labeling and comparison with authentic standards are then used to elucidate the structures 
of small molecules derived from conjugation to biological RNAs.  Using this new method, we 
identified nicotinamide adenine dinucleotide (NAD) as covalently attached to unknown cellular 
RNA(s) in bacteria and some eukaryotes.  We also characterized basic features of NAD-RNA 
conjugates from these organisms, including the nature of the NAD-RNA linkage, the inability of 
E. coli RNA polymerase to initiate transcription with NADH in vitro, and the size distribution of 
NAD-linked RNAs.  Our approach has the potential to provide a more complete understanding 
of the chemical diversity of cellular RNA and add to the biological functions of RNA. 
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Chapter Two: 
 
The Development and Application of a Nuclease-Based Screen 
that Reveals NAD-Linked RNA 
 
Ye Grace Chen, Walter Kowtoniuk, Yinghua Shen, David R Liu 
Ye Grace Chen and Walter Kowtoniuk developed the nuclease-based screen.  Ye Grace Chen 
and Yinghua Shen developed the soft ionization LC/MS method.  Walter Kowtoniuk carried out 
the in vitro transcription initiation by E. coli polymerase experiment. Ye Grace Chen conducted 
and analyzed all of the other experiments described. 
 
Adapted from “LC/MS analysis of cellular RNA reveals NAD-linked RNA." 
Nature Chemical Biology (2009) 5(12): 879-881. 
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2.1 Introduction 
The known chemical diversity of cellular RNA remains modest compared with the 
rapidly growing diversity of RNA’s known biological roles.  In this chapter, we describe the 
development and application of a general method to detect small molecule-linked RNAs that 
does not rely on the chemical reactivity of the small molecule, and thus in principle enables the 
detection of any cellular small molecule-RNA conjugate.  We validated the method by detecting 
known tRNA and rRNA modifications in Escherichia coli and Streptomyces venezuelae RNA.  
When applied to E. coli and S. venezuelae RNA, the method revealed NAD-linked RNA, in 
addition to a number of other previously unreported putative small molecule-RNA conjugates.  
Subsequent experiments to characterize NAD-linked RNA revealed that the NAD group is 
attached to unknown E. coli and S. venezuelae RNA(s) at the 5’ terminus and cannot be installed 
in vitro through aberrant transcriptional initiation by E. coli RNA polymerase.  Strikingly, 
quantitation using authentic standards indicates that NAD-linked RNA is present at ~3,000 
copies per cell, a level comparable to that of several of the more abundant aminoacylated tRNAs.  
These results provide a new example of a biological small molecule-RNA conjugate, further 
support our conclusion that the chemical diversity of cellular RNA includes unanticipated classes 
of molecules, and highlight the value of the general chemical screening method developed in this 
work. 
 
2.2 A More General Method for Detecting Cellular Small Molecule-RNA Conjugates 
We previously developed two methods to detect cellular small molecule-RNA conjugates 
that depend on the chemical lability of the small molecule or nucleotide to which the small 
molecule is attached.105  We compared total RNA that was digested with nuclease, and then 
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treated with base or nucleophile to samples that were treated in conditions that would leave the 
nucleotide intact, and analyzed by reverse phase liquid chromatography/electrospray ionization-
mass spectrometry (LC/ESI-MS).  By treating half of the sample with either base or nucleophile 
and the other half with conditions that should not affect RNA cleavage, we discovered base- or 
nucleophile-labile small molecules that are linked to RNA. 
In order to generalize the screen that detects novel small molecule modifications on 
RNA, we determined that the samples for comparative analysis could be derived from (i) RNA 
treated with a nuclease enzyme that cleaved the RNA to mononucleotides, and (ii) RNA treated 
with heat-inactivated nuclease that left the RNA intact but contained all other small molecules 
introduced or generated during RNA isolation and sample processing (Fig. 2.1).   Non-canonical 
species more abundant in the active nuclease-treated sample than in the inactive nuclease-treated 
sample could then be identified as possible novel small molecule-RNA conjugates, regardless of 
their chemical lability.  Based on the sensitivity of our current LC/MS methods, this method 
would be able to detect ~0.5 pmol of a given nucleotide, corresponding to detection of 
modifications that are present at ~30 copies per bacterial cell.  This sensitivity represents a ~200-
fold improvement on previous efforts to study modified nucleotides, which usually focused on 
specific fractions of the cellular RNA (e.g., tRNAs) and were limited to studying nucleotides at 
high abundance levels of greater than or equal to ~2%; in E. coli this abundance level 
corresponds to ~4,400 copies per cell.106,107 
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Figure 2.1. The general method for biological small molecule-RNA conjugate discovery 
developed in this work.  The paired samples for comparative LC/MS analysis were generated by 
treatment with active nuclease P1 versus treatment with heat-inactivated nuclease P1 under 
otherwise identical conditions. 
 
2.3 Validation Using Aminoacylated tRNAs and Known Nucleoside Modifications 
The methods outlined above were implemented and applied to Halobacterium salinarum, 
Saccharomyces cerevisiae, E. coli and S. venezuelae RNA (Fig. 2.1).  Whole cellular RNA was 
subjected to size-exclusion chromatography and the macromolecular fraction (greater 
than ~2,500 Da) was divided into two halves.  One half was treated for 40 min at 37 °C with 
nuclease P1, an endonuclease that cleaves RNA to generate mononucleotides with a 3’ hydroxyl 
and a 5’ phosphate.108  The second half was treated with heat-inactivated nuclease P1 under 
otherwise identical conditions.  Both samples were subjected to size-exclusion chromatography 
again and the small-molecule fraction from each was retained.  The two samples were then 
analyzed by LC/MS.  Peaks with corresponding retention times containing species with similar 
mass:charge ratios (m/z) from the two samples were computationally paired, and their relative 
abundances were calculated.105  Species with greater abundance in the active nuclease-treated 
sample than in the inactive heat-inactivated nuclease sample were considered candidate 
nucleotides for further study (Fig. 2.1).   
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Compared with our previous methods, this more general approach places a greater burden 
on the downstream processing of the resulting comparative LC/MS data.  We therefore 
computationally filtered out (Fig. 2.2) canonical mono- and di-ribonucleotides, all known 
modified nucleotides including aminoacylated AMPs, all known base-modified tRNA and rRNA 
nucleotides, and the common ionization fragments and isotope peaks from all of these species.  
This set of known species is significantly larger than the set previously used in the chemical 
cleavage methods due to the more comprehensive nature of this approach. 
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Figure 2.2.  Computational filtering to identify putative unknown small molecule-RNA 
conjugates.  (a) Following XCMS analysis,109 MS adducts and isotopic species were filtered out 
to generate a list of putative small molecule-RNA conjugates.  [2M-H]- adducts were filtered out 
by removing the heavier of any two peaks separated in m/z value by M Da with the same 
retention time.  Heavy isotope species were filtered out by removing any peak with a 
corresponding peak 1.00627 Da (the mass of a neutron) lower in m/z with identical retention  
a b 
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Figure 2.2. (continued): times.  From the resulting filtered list we identify known modified 
nucleobases were identified, shown in (b).  Isomeric nucleotides are listed sequentially, with 
expected m/z values shown once. 
 
To validate the method, we processed whole E. coli and S. venezuelae cellular RNA and 
searched for species enriched in the active nuclease sample that had masses and retention times 
consistent with those of amino acid-linked adenosine monophosphates and nucleobase 
modifications known to exist in bacteria.  Of the 20 major 3’-aminoacyl adenosine 
monophosphates, 16 (80%) were detected as enriched at least 2-fold in the active nuclease-
treated samples compared with the heat-inactivated nuclease-treated samples in E. coli (Fig. 
2.3a).  In addition, 31 species enriched at least 2-fold were observed with masses consistent with 
the masses of known RNA nucleobase modifications (Fig. 2.3b).  In S. venezuelae, 16 aminoacyl 
adenosine monophosphates (Fig 2.4a) and 26 known RNA nucleobase modifications were 
detected as enriched at least 2-fold.  An enrichment threshold of 2-fold represented a reasonable 
balance between detecting the maximum number of known 3’-aminoacyl adenosine 
monophosphates and nucleobase modifications, and minimized the number of irreproducible 
false-positive signals resulting from experimental noise.  We note that several of the detected 
nucleobase modifications such as queuosine, 5-hydroxyuridine, and 2-methylthio-N6-
isopentenyladenosine are not expected to be base- or nucleophile-labile, and were not detected 
by our previous methods that relied on base cleavage or nucleophile cleavage.105  These results 
validate the ability of the nuclease versus heat-inactivated nuclease-based method to detect the 
presence of known small molecule-RNA conjugates from whole cellular RNA, including 
conjugates that are not chemically labile.  
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Figure 2.3.  (a) 3’-aminoacyl adenosine monophosphates from total E. coli RNA detected with 
the nuclease-based method.  (b) Species detected by the nuclease digestion method that are 
consistent with known rRNA and tRNA nucleotide modifications from total E. coli.  Although 
plausible identifications are shown based on high-resolution LC/MS data, we note that definitive 
identifications require comparison with authentic samples.  Isomeric nucleotides are listed 
sequentially, with expected m/z values shown once. 
 
 
 
b a 
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Figure 2.4.  (a) 3’-aminoacyl adenosine monophosphates from total S. venezuelae RNA detected 
with the nuclease-based method.  (b) Species detected with the nuclease digestion method that 
are consistent with known rRNA and tRNA nucleotide modifications from total S. venezuelae.  
Although plausible identifications are reported based on high-resolution LC/MS data, definitive 
identifications require additional comparisons with authentic samples of each modified 
nucleotide.  Isomeric nucleotides are listed sequentially, with expected m/z values shown once. 
 
2.4 Application of the Nuclease-Based Screen to Halobacterium salinarum RNA 
The study of small molecule-RNA conjugates may be particularly interesting in archaea 
due to their fundamental biological differences compared with bacteria and eukaryotes (Fig. 2.5).  
For example, archaea contain membrane lipids composed predominantly of isoprenoid glycerol 
diethers or diglycerol tetraethers, rather than glycerol esters, and their ribosomes have substantial 
rRNA structural differences compared to bacteria and eukaryotes.110-112  Archaea also contain 
archaea-specific post-transcriptional RNA modifications,54,113 including at least a dozen unique 
tRNA nucleobase modifications that are not known to exist in bacteria or eukaryotes.85  Based on 
these differences, we anticipate that the application of our methods to archaea will continue to 
b a 
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expand our knowledge of the chemical diversity of biological RNA through examples that may 
not be present in bacteria or eukaryotes. 
   
 
Figure 2.5. Phylogenetic tree and key biochemical difference among the three domains of 
life.110,111,114 
 
Since we hypothesized that novel small molecule-RNA conjugates may exist in modern 
cells as evolutionary fossils, haloarchaea are of particular interest for study.  Halophiles have 
been proposed as the earliest living cells to evolve, resulting from the concentration of both salts 
and organic compounds in an evaporitic environment giving rise to the primordial soup.115,116  Of 
the archaean organisms, haloarchaea are among the most extensively studied due to their relative 
ease of laboratory culturing, transformability,  genetic malleability, and their known genome 
sequences.117  Halobacterium salinarum requires only high salt concentrations and aeration to 
grow, and the prevalent interest in understanding the functioning of cellular machinery under 
such salt concentrations has aided the development of methodologies that we can apply to 
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studying small molecule-RNA conjugates in H. salinarum.117  For example, transformations and 
the creation of mutant strains in H. salinarum are now commonplace.118,119  Transcriptome and 
proteome analyses have been also conducted for H. salinarum,120-122 as well as a full genome 
sequencing,114 and together these provide invaluable resources in our investigation of archaean 
small molecule-RNA conjugates.  
We isolated total RNA from H. salinarum and treated half with nuclease P1 and the other 
half with heat-inactivated nuclease P1.  Both sets of samples were subjected to size exclusion 
chromatography prior to LC/MS analysis and computation processing.  In addition to detecting 
known modifications, we observed, on average, 11 of the 20 major aminoacyl-adenylates.  The 
method also detected nine non-canonical species that were enriched at least 2-fold from the 
screens of H. salinarum total RNA (Fig. 2.6).  We obtained initial MS/MS fragmentation data for 
each of the species. 
m/z rt (min) 
Nuclease/Heat-Inactivated 
Nuclease Enrichment 
536.070 2.947 115.530 
394.104 2.954 66.775 
898.381 3.354 22.949 
395.105 2.964 14.867 
572.109 4.540 13.996 
759.628 23.151 6.595 
559.045 3.024 5.996 
446.132 7.286 5.748 
421.164 17.005 5.505 
 
Figure 2.6. The nuclease-based screen was applied to H. salinarum and nine novel small 
molecules were detected as reproducibly enriched. 
  
While we were able to identify nucleotide components of the small molecule 
modifications of RNA, further structural characterization was elusive due to sample preparation 
limitations.  In the initial studies, H. salinarum were cultured in baffled flasks for twelve to 
fourteen days after inoculation with a saturated starter culture.  In order for the halophiles to 
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grow properly, a high oxygen supply needed to be balanced without overly vigorous lateral 
shaking since there have been reports of culture lysis under those conditions.123  From the flask 
cultures, an average of ten mg of total RNA were extracted from eight liters of cells.  Since each 
screen required at least three mg of total RNA and more for structure elucidation experiments, 
other methods of large scale culturing were investigated.  H. salinarum were then grown in 
fermenters, which increased the cell density before growth was inhibited, and thus, the amount of 
total RNA extracted.  However, the sample demands of the early phase screening coupled with 
the long doubling time H. salinarum led us to explore other organisms that might be more 
technically tractable for investigation of small molecule-RNA conjugates. 
 
2.5 Application of the Nuclease-Based Screen to Saccharomyces cerevisiae RNA 
Eukaryotes, such as yeast, are attractive species for our investigations, due to their ease of 
laboratory culturing and well-developed molecular biology protocols for their study.124-127  
Furthermore, preliminary evidence suggests the potential biological relevance of small molecule-
RNA conjugates in eukaryotes.  That the lack of certain nucleoside modifications leads to 
phenotypic changes in yeast, such as ceasing sporulation, indicates that the post-transcriptional 
modifications are involved in gene regulation or cellular signaling.128  A comprehensive 
investigation of small molecule-RNA conjugates in S. cerevisiae using the nuclease-based 
screening method may therefore lead to the discovery of new biological pathways.129  Thus, we 
applied the previously developed methods to the thorough search for cellular small molecule-
RNA conjugates in the eukaryote S. cerevisiae.  When S. cerevisiae total RNA was subjected to 
the nuclease-based screen, 23 unknown species was enriched at least 2-fold (Fig. 2.7).  Two 
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independent biological replicates generated enrichment factors with a trial-to-trial correlation 
coefficient of 0.94. 
m/z rt (min) 
Nuclease/Heat-Inactivated 
Nuclease Enrichment 
459.250 8.306 122.818 
917.430 9.152 79.308 
415.220 10.570 76.325 
781.355 5.632 70.300 
721.321 5.301 58.258 
490.228 5.459 44.339 
902.408 7.336 36.603 
723.294 5.641 36.015 
830.439 10.553 29.353 
749.361 6.946 25.578 
446.111 5.658 25.279 
696.281 5.846 16.857 
682.254 5.275 16.815 
585.513 6.471 12.554 
493.243 9.334 12.053 
509.239 7.587 11.315 
520.409 8.918 10.949 
810.541 10.981 6.594 
636.442 16.306 5.852 
631.417 14.826 4.374 
980.699 11.999 3.455 
608.408 14.861 3.365 
690.964 12.043 3.198 
 
Figure 2.7. The nuclease-based screen was applied to S. cerevisiae and twenty-three novel small 
molecules were detected as reproducibly enriched. 
 
2.6 Application of the Nuclease-Based Screen to Escherichia coli and Streptomyces 
venezuelae RNA 
When applied to E. coli RNA, the method described above also detected 24 non-
canonical, unknown species enriched at least 2-fold (Fig. 2.8a).  In S. venezuelae, this method 
yielded 28 unknown species that were enriched 2-fold or more (Fig. 2.8b).  Independent 
replicates starting with distinct cell cultures generated enrichment factors with trial-to-trial 
correlation coefficients of 0.93 in S. venezuelae (Fig. 2.8c) and 0.90 in E. coli (Fig. 2.8d).  None 
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of the observed unknown species were detected from total E. coli or S. venezuelae RNA if active 
nuclease P1 was omitted, or if active nuclease P1 treatment was replaced with incubation in 
formamide and/or 10 mM EDTA at 95°C, conditions expected to abrogate RNA secondary 
structure.  These results suggest that the species in Fig. 2.8 arise from nuclease-mediated RNA 
cleavage, and not from the release of small molecules non-covalently associated with RNA.  
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Figure 2.8.  (a) Unknown species detected by the nuclease digestion method applied to E. coli 
RNA that satisfy the criteria described in the text.  (b) Unknown species detected by the nuclease 
digestion method applied to S. venezuelae RNA that satisfy the criteria described in the text.  The 
NAD fragment is listed in red, and the CoA derivatives are listed in blue. (c) Result of two 
independent trials (r = 0.90) of the method described in the main text applied to total E. coli  
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Figure 2.8. (continued): RNA.  The observed species include 16 3’-aminoacyl adenosine 
monophosphates, 33 known nucleotide modifications, the four canonical RNA nucleotides, 3’-
dephospho-CoA and two thioester derivatives, and 24 additional unknown species with a 
control:base ratio ≥ 2-fold.  (d) Results of two independent trials (r = 0.93) of the nuclease 
method applied to total S. venezuelae RNA.  The observed species include 16 aminoacyl 
adenosine monophosphates (red), 25 known nucleobase modifications (yellow), four canonical 
RNA nucleotides (green), 3’-dephospho-CoA and 3’-dephospho-CoA thioesters (dark blue),105 
NAD (purple), and 24 additional unknown species with a nuclease:control ratio ≥ 2-fold (light 
blue), 20 of which were not discovered with our previously reported nucleotide cleavage 
method.105  In both (c) and (d) each point represents the average of three experiments. 
 
2.7 Structural Elucidation of m/z = 540.0533 as a Fragment of NAD 
One unknown species from both E. coli and S. venezuelae that was enriched 8-fold in the 
nuclease versus heat-inactivated nuclease samples was [M-H]– m/z = 540.0533 (Fig. 2.9a and b).  
The data sets generated from culturing S. venezuelae in media containing 13C-glucose as the sole 
carbon source, or in media containing 15N-ammonium sulfate as the sole nitrogen source, 
resulted in mass increases of this species of 15 Da and 5 Da, respectively (Fig. 2.9c).  These 
results indicated that the unknown species contained 15 carbon atoms and five nitrogen atoms, 
enabling us to deduce a molecular formula of C15H20N5O13P2 (expected [M-H]- m/z = 540.0538).  
The MS/MS spectrum of this ion further indicated that ADP was a major fragment of this ion 
(Fig. 2.10).  We therefore reasoned that the 540.0533 Da species likely consists of a 115.0395 Da 
group (C5H7O3) attached to the pyrophosphate of ADP.  
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Figure 2.9.  A small molecule-linked nucleotide of [M-H]- m/z = 540.0533 from E. coli and S. 
venezuelae RNA.  (a) The extracted ion chromatograph (EIC) for [M-H]- m/z = 540.0533 from E. 
coli RNA exposed to active nuclease P1 (cleavage conditions) or to heat-inactivated nuclease P1 
(control conditions).  (b) Same as (a), but using S. venezuelae RNA.  (c) Isotope-labeled S. 
venezuelae total RNA enables determination of the molecular formulas of [M-H]- m/z = 
540.0533.  S. venezuelae was cultured in media containing 13C-glucose as the sole carbon source, 
or in media containing 15N-ammonium sulfate as the sole nitrogen source.  The resulting RNA 
species when subjected to the nucleotide cleavage method resulted in mass increases indicating 
that the [M-H]- m/z = 540.0533 ion contains 15 carbon atoms and five nitrogen atoms.  (d) The 
EICs for [M-H]- m/z = 662.1018 from E. coli RNA or (e) from S. venezuelae RNA digested with 
nuclease P1 or control conditions (heat-inactivated nuclease incubation).  (f) EIC comparison of 
E. coli cellular RNA nuclease P1 digestion products with authentic NAD.  (g) Plausible structure 
of NAD-linked cellular RNA.  We note that our data is also consistent with RNA attachment to 
the 2’ hydroxyl of NAD, or to either of the nicotinamide-linked ribose hydroxyl groups. 
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Figure 2.10. MS/MS fragmentation of E. coli cellular species [M-H]- m/z = 662.1018 and 
comparison with authentic NAD confirms the assignment of the [M-H]- m/z = 662.1018 as NAD.  
A table of plausible fragment ion structures is provided. 
 
The formula C5H7O3 suggests that the non-ADP portion of the molecule contains two 
degrees of unsaturation, consistent with an unsaturated ribose ring.  Having considered many 
possible chemical structures for C5H7O3 attached to ADP, we hypothesized that the most 
plausible source of a five-carbon group conjugated to ADP containing two degrees of 
unsaturation is an elimination reaction on an adenosine-containing cofactor.  We therefore 
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speculated that the [M-H]- m/z = 540.0533 ion is a breakdown product of a larger small 
molecule-RNA conjugate that undergoes elimination during MS ionization.  In support of this 
model, an MS analysis performed under milder ionization conditions (Fig. 2.9f) showed a [M-H]- 
m/z = 662.1032 species that appeared at the same retention time as the [M-H]- m/z = 540.0533 
species.  As we further adjusted ionization conditions, the signal intensity of [M-H]- m/z = 
662.1032 increased to become the predominant peak.  Collectively, these observations led us to 
propose that the [M-H]- m/z = 540.0533 species is a fragment of nicotinamide adenine 
dinucleotide (NAD) (expected [M-H]- m/z = 662.1018).  This hypothesis has been confirmed by 
LC/MS and MS/MS comparisons of the cellular species with authentic NAD (Fig. 2.9f and Fig. 
2.10).  Analysis of E. coli and S. venezuelae RNA using the milder ionization conditions 
revealed that [M-H]- m/z = 662.1032 was also significantly enriched (8-fold) in the nuclease 
versus heat-inactivated nuclease samples (Fig. 2.9c and d), in support of these conclusions. 
NADH, the reduced form of NAD, is not detected as a small molecule-RNA conjugate by 
our nuclease-based method.  However, the absence of this species (expected [M-H]- m/z = 
664.1175) does not rule out the presence of NADH-linked cellular RNA.  Indeed, when authentic 
NADH was added directly to nuclease digestion reactions, a very low NADH signal was 
observed.  Instead, the addition of NADH resulted in an increased NAD signal (Fig. 2.11), 
suggesting that any NADH-RNA present likely oxidized to NAD-RNA during RNA isolation 
and sample processing.  
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Figure 2.11.  NADH oxidizes to NAD during RNA isolation, sample processing and analysis.  
The mock RNA isolation mimicked the total RNA isolation from bacteria protocol, but omitted 
the isopropanol precipitations and size-exclusion chromatography steps.  Observed ion counts 
are converted into pmol based on NAD and NADH standard curves. 
 
We note that under base cleavage conditions (pH 8) previously used to discover CoA-
linked RNA, the abundance of NAD in the nuclease-treated samples is virtually identical (116 
vs. 108 ion counts) to the abundance under control conditions (pH 4.5) and thus would have been 
overlooked using our previous methods.105 
 
2.8 NAD is Covalently Linked to RNA 
Since NAD is prevalent as a cellular metabolite and cofactor,130 we sought to confirm that 
the detected NAD species was not an intracellular contaminant unexpectedly carried through the 
RNA purification and size exclusion.  To ensure that the NAD signal was from a conjugate, we 
spiked varying quantities of authentic NAD or NADH into E. coli and S. venezuelae cell lysates, 
and repeated the RNA isolation, nuclease P1 digestion, and LC/MS analysis.  Even though we 
added up to 10,000-fold more NAD and NADH than was observed in the unspiked samples, the 
abundance of the corresponding NAD species did not change significantly (Fig. 2.12).  These 
results demonstrate that the NAD species observed in our experiments on E. coli and S. 
venezuelae RNA cannot be accounted for by endogenous NAD (or by the oxidation of 
endogenous NADH), and further support the conclusion that these species arise from cellular 
small molecule-RNA conjugates. 
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Figure 2.12. Spiking large quantities of NAD or NADH into E. coli cell lysate before RNA 
isolation and treatment with active nuclease P1 does not change the observed ion counts of these 
species, indicating that the observed NAD signals do not arise from small-molecule NAD 
contaminants.  Error bars represent the standard deviation of three independent trials.  
 
Two nonenzymatic methods to confirm that the NAD signal detected is due not to small 
molecule contamination but to covalent attachment to NAD, is to subject total RNA to ethanol 
precipitation and/or size exclusion chromatography.  We precipitated total RNA once or twice 
sequentially, digested with nuclease P1 and measured the NAD signal detected by LC/MS 
analysis.  Since ethanol precipitation removes small molecules from nucleic acids, we expected 
and indeed observed, stable NAD signal from LC/MS analysis, which indicated NAD was 
conjugated to RNA (Fig. 2.13). 
Modification m/z  
Ion Counts After Nuclease 
Digestion of One Ethanol 
Precipitation 
Ion Counts After Nuclease 
Digestion of Two Ethanol 
Precipitation 
AMP-Leu 459.13 1840 1250 
t6A 491.1 19 13 
NAD 540.05 32 10 
 
Figure 2.13. Ion counts of NAD and other RNA modifications remain stable after two ethanol 
precipitations suggesting that they are indeed covalently linked to RNA.  Total RNA was ethanol 
precipitated, digested with nuclease P1 and followed by LC/MS analysis.   
 
Like ethanol precipitation, size exclusion chromatography separates macromolecules 
from small molecules.  Total RNA was subjected to size exclusion chromatography, where both 
the macromolecule and small molecule fractions were collected.  Each of the fractions were 
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digested with nuclease P1 and analyzed by LC/MS.  If the modifications are covalently linked to 
RNA, they should only be detected in the macromolecule fraction.  Accounting for loss of 
material through the size exclusion chromatography (as determined by comparing the signal to a 
known tRNA modification), we observed consistent NAD signal in the appropriate fraction (Fig. 
2.14). 
Modification  m/z  
Ion Counts From 
Macromolecule 
Fraction  
Ion Counts From First 
Small Molecule 
Fraction 
Ion Counts From 
Second Small Molecule 
Fraction  
AMP-Leu 459.13 49 n/d above noise n/d above noise 
t6A 491.1 7590 558 19 
NAD 540.05 256 n/d above noise n/d above noise 
 
Figure 2.14. Nucleotide modifications that are covalently linked to RNA are detected in the 
macromolecule fraction and not the small molecule fraction during size exclusion 
chromatography.  Total RNA was subjected to size exclusion chromatography and the following 
were collected: macromolecule, first small molecule, and second small molecule fractions.  Each 
fraction was subjected to nuclease P1 digestion and analyzed by LC/MS.   
 
2.9 Characterization of the NAD-RNA Linkage 
 The structure of NAD led us to hypothesize that NAD is a 5’ RNA modification.  
Because nuclease P1 catalyzes the attack of a water molecule on RNA to generate 5’-
phosphonucleotides,108 all nuclease P1 digestion products other than the nucleotides at the 5’ 
termini undergo a mass shift when the digestion is performed in the presence of isotopically 
labeled water, compared with digestion in unlabeled water.  We carried out nuclease P1 digestion 
of total RNA from both E. coli and S. venezuelae in 18O-enriched water.  As expected, 3’-Phe-
AMP exhibited a +2 Da mass shift when the digestion was carried out in 18O water compared to 
in 16O water (observed [M-H]– m/z = 495.1286; expected [M-H]– m/z = 495.1285) (Fig. 2.15a).  
In contrast, there was no mass shift for NAD in both isotopically-labeled and unlabeled water 
(Fig. 2.15b).  This finding is consistent with a model in which NAD is present at the 5’ termini of 
RNA (Fig. 2.9g). 
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Figure 2.15.  In the presence of 18O water, all nuclease P1 digestion products other than the 
nucleotides at the 5’ ends of substrates will exhibit a +2 Da mass shift compared with the 
products arising from digestion in 16O water.  (a) Phenylalanyl AMP, a known small molecule-
RNA conjugate that exists at the 3’ end of tRNA, exhibits the expected +2 Da shift.  (b) No mass 
shift is observed in the case of NAD, indicating that this modification is located at the 5’ 
terminus of the RNA(s). 
 
Unlike nuclease P1, RNase A mediates RNA cleavage by catalyzing the attack of a 2’-
hydroxyl group to form a 2’, 3’-cyclic phosphonucleotide, which then can be hydrolyzed to 
generate a nucleotide 3’-monophosphate.  Products of RNase A digestion, with the exception of 
the 3’-terminal base, are therefore monophosphonucleotides.131-133  When total RNA from E. coli 
and S. venezuelae was digested with RNase A, the internal rRNA nucleoside modification 
N6,N6’-dimethyladenine134 was detected as a mixture of the cyclic and acyclic 
monophosphonucleotides, as expected (observed [M-H]- m/z = 356.0772 and m/z = 374.0873, 
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expected [M-H]- m/z = 356.0760, and m/z = 374.0866).  RNase A digestion also generated 
monophosphorylated NAD (observed [M-H]- m/z = 742.0678, expected [M-H]- m/z = 742.0682).  
Similar results were observed when authentic NAD-linked RNA, generated by T7 RNA 
polymerase135 was digested with RNase A (observed [M-H]- m/z = 742.0653).  These results are 
consistent with the nuclease P1 digestion results and further support a model in which the NAD 
group is covalently linked not to the 3’ terminus but to the 5’ terminus of RNA. 
  
2.10 Cellular NAD-RNA Is Surprisingly Abundant 
We quantified the amount of NAD-linked RNA in E. coli cells using two methods.  First, 
we generated a standard curve that relates known quantities of authentic NAD (quantified by 
spectrophotometry) to observed ion counts under both the original and the milder ionization 
conditions.  Ion counts from E. coli RNA when plotted on the resulting curve result in the 
estimate of ~3,000 copies of NAD-RNA per E. coli cell for both ionization conditions (Fig. 
2.16a and b).  In a second approach, we added a known quantity of authentic NAD to the 
biological nuclease P1-digested RNA sample before LC/MS analysis, and used the resulting 
increase in the NAD ion count to relate added NAD concentration and observed signal.  This 
second method resulted in a similar estimate of ~3,300 copies of NAD-RNA per E. coli cell (Fig. 
2.16b).  The estimated abundance level is comparable to that of aminoacylated tRNAs in the 
second highest quartile of abundance in E. coli such as Ile-charged tRNAIle (~2,800 copies per 
cell), Ala-charged tRNAAla (~3,100 copies per cell), or Thr-charged tRNAThr (~2,100 copies per 
cell) (Fig. 2.17).136  Therefore, these results suggested that NAD-linked RNA is one of the more 
abundant known cellular small molecule-RNA conjugates discovered to date.  We observed 87 
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fmol of NAD-RNA per µg of E. coli RNA and 142 fmol of NAD-RNA per µg of S. venezuelae 
RNA.  
 
Figure 2.16.  Standard curve relating known NAD quantities to the abundance of the major 
daughter ion ([M-H]- m/z = 540.0538) or of the parent ion ([M-H]- m/z = 662.1018).  These 
curves were used to determine the amount of NAD-RNA per E. coli cell.  The amount of NAD 
signal arising from nuclease P1 digestion of total E. coli RNA is indicated with the green lines.  
The purple line indicates the observed NAD signal when 47 pmols of authentic NAD is added to 
nuclease P1-digested total E. coli RNA.  All three cases indicate that there are ~43-47 pmol of 
NAD-RNA per 500 µg of E. coli RNA, which corresponds to ~3,000-3,300 copies of NAD-RNA 
per E. coli cell.  Error bars in a and b represent the standard deviation of three independent trials. 
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charged tRNA molecules/cell 
Leu 9023 
Arg 6678 
Gly 6496 
Val 5105 
Glu 4717 
Ala 3867 
Ser 3812 
Ile 3474 
Thr 2656 
Met 2632 
Asp 2396 
Pro 2201 
Tyr 2030 
Lys 1924 
Gln 1645 
Cys 1587 
Asn 1193 
Phe 1037 
Trp 943 
His 639 
tRNA (total) 205,000 
  
tmRNA 700 
23S rRNA 18,700 
16S rRNA 18,700 
5S rRNA 18,700 
mRNA 4,000 
RNA from primase 11 
 
Figure 2.17.  Abundance of different RNAs in an E. coli cell, adapted from Jakubowski and 
Goldman (1984). J Bacteriol 158(3): 769-776.136 
 
2.11 Transcriptional Initiation by E. coli RNA Polymerase In Vitro Cannot Account for 
Observed Levels of NAD-RNA 
 Structural similarities between NAD and ATP led us to speculate that NAD might be 
incorporated into RNA at the 5’-terminus through aberrant transcriptional initiation with NAD or 
its reduced form instead of ATP.  Indeed, NAD has been incorporated into the 5’-terminus of 
RNA transcripts in vitro using T7 RNA polymerase.135  To test if transcriptional initiation was 
responsible for incorporating NAD into RNA transcripts, we used E. coli RNA polymerase to 
carry out in vitro transcription in the presence of high concentrations of NADH using two 
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templates.  The first template was a modified pUC19 plasmid, which encoded an adenosine at 
the +1 position of each of its four predicted transcripts.  An in vitro transcription reaction 
containing 0.5 mM of each NTP and either 0.5 mM or 5 mM of NADH yielded 222 µg or 174 µg 
of RNA, respectively.  When this RNA was purified, digested with nuclease P1, and analyzed by 
LC/MS, no NAD or NADH was detected (Fig. 2.18).  The second template used was E. coli 
genomic DNA.  In vitro transcription in the presence of either 0.5 mM or 5 mM of NADH 
yielded 78 µg or 70 µg of RNA.  Once again, this material contained no detectable NAD or 
NADH after nuclease P1 digestion (Fig. 2.18).  In contrast, when an authentic 5’-NAD-linked 
transcript (generated using T7 RNA polymerase) was spiked into an in vitro transcription 
reaction and processed in the same way, NAD-linked RNA was readily detected (Fig. 2.18).  
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Figure 2.18. In vitro transcription with E. coli RNA polymerase in the presence of NADH does 
not generate significant quantities of NAD-linked RNA.  E. coli RNA polymerase was used to 
generate RNA in vitro from plasmid or genomic DNA templates in the presence of 0.5 mM or 
5.0 mM of NADH.  When the resulting RNA was digested with nuclease P1 and analyzed by 
LC/MS, the observed (NAD+NADH) signal (column 8) was much lower than the expected ion 
counts if the observed quantities of NAD-RNA in E. coli arise from aberrant transcriptional 
initiation with NAD or NADH (column 6).  Spiking 1.0, 2.3, or 4.5 pmol of authentic NAD-
linked RNA (generated with T7 RNA polymerase; see the main text) into the in vitro 
transcription reaction resulted in observed ion counts that were consistent with, but not 
significantly greater than, the expected levels of NAD ions from the spiked material (column 7).  
Column 6 lists the expected ion counts of (NAD+NADH) assuming that the fraction of RNA 
generated from in vitro transcription under these conditions is at least as great as that observed 
from E. coli cellular RNA. 
 
Based on the above estimated abundances of NAD-RNA in E. coli, we expect to obtain 
more than 19 pmol of NAD from ~222 µg of A-initiated RNA, and 6.8 pmol of NAD from ~78 
µg of RNA transcribed from the E. coli genome, if transcriptional initiation were predominantly 
responsible for the NAD-RNA conjugates.  Such quantities would be readily detected by our 
methods, which can reliably detect less than or equal to 0.5 pmol of NAD.  If the inability of E. 
coli RNA polymerase to incorporate these levels of NAD in vitro indicates the inability to do so 
in cells, NAD groups are likely installed following transcriptional initiation. 
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2.12 NAD Radical Formation May Contribute to the Unexpectedly High +1 Da Isotope 
Peak in the Authentic and Cellular NAD Spectra 
Based on the natural isotope abundances, the expected abundance ratio of the +1 Da 
isotope peak at [M-H]- m/z = 663.1069 to the isotope peak at [M-H]- m/z = 662.0986 is equal to 
26.8%.  However, the observed ratio is higher for both authentic and cellular RNA-derived NAD 
samples (Fig. 2.19a).  The increase in the [M-H]- m/z = 663.1069 signal might be due to the 
contributions of other species that either coelute with NAD or are produced during ionization.  
For example, an NAD radical anion (Fig. 2.19b) would be observed primarily as a [M-H]⋅- m/z = 
663.1091 species.  A mixture of NAD anion and NAD radical anion species during ionization 
would result in a higher-than-expected abundance of the NAD +1 Da peak.  
 
 
Figure 2.19.  NAD radical may contribute to the [M-H]- m/z 663.1069 signal in the authentic and 
cellular NAD spectra.  (a) Mass spectra of cellular and authentic NAD, and the theoretical 
isotope profiles for NAD and NAD radical.  (b) Structure of NAD radical. 
 
 
a b 
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2.13 Conclusions 
 The method developed in this work enables the detection, in principle, of any small 
molecule-RNA conjugate.  The application of this method resulted in the discovery of NAD-
RNA in E. coli and S. venezuelae, bacteria from two different phyla, as well as in the detection of 
a variety of additional unknown, non-canonical small molecule-RNA conjugates.  Following the 
recent discovery of CoA-linked RNA, these results further indicate that the chemical diversity of 
biological RNA is even greater than suggested by such known examples as aminoacylated 
tRNAs, RNAs containing modified nucleobases, and, in eukaryotes, 5’-capped mRNA.   
We note that under base cleavage conditions (pH 8) previously used to discover CoA-
linked RNA, the abundance of NAD in the nuclease-treated samples is virtually identical (116 
vs. 108 ion counts) to the abundance under control conditions (pH 4.5) and thus would have been 
overlooked using our previous approaches.105  The inability to detect NAD-linked RNA under 
base cleavage conditions necessitates a more general method for the discovery of less reactive 
small molecule-RNA conjugates as developed in this work. 
The NAD group is linked to RNA(s) at the 5’ terminus.  On average we observe ~3,000 
NAD-RNA molecules per E. coli cell, which suggests that NAD-linked RNAs together are 
approximately as abundant as Phe-linked tRNA in E. coli,136 ~4-fold more abundant than E. coli 
tmRNA,137 and ~300-fold more abundant than the short RNAs generated by DNA primase 
during DNA synthesis.138,139  Our in vitro transcription experiments suggest that non-specific 
transcriptional initiation is not the primary mechanism for NAD-RNA formation.  It is possible 
that additional cellular components are necessary for a non-specific transcription initiation 
pathway for NAD incorporation.  Our results also do not rule out a gene-specific transcription 
initiation pathway for NAD.  Studies are ongoing to identify additional small molecule-RNA 
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conjugates, to characterize the RNA species to which these groups are attached, and to evaluate 
functional roles of such groups in the cell.  
 
2.14 Experimental Methods 
General.  Unless otherwise noted, all starting materials were obtained from commercial 
suppliers and were used without further purification. 
 
Bacterial Growth and Crude Nucleic Acid Isolation.  E. coli TOP10 (Invitrogen) was cultured 
to OD600 = 0.7-0.8 at 37ºC in 2 L LB broth Miller (EMD Bioscience).  S. venezuelae ATCC 
#10595 was cultured to OD600 = 0.7-0.8 at 30 ºC in 2 L MYME media (100 g/L sucrose, 10 g/L 
maltose, 5 g/L peptone, 3 g/L yeast extract, 3 g/L malt extract).140  All subsequent manipulations 
of cells were carried out on ice or at 4 °C.  The bacteria were centrifuged (10 min at 6,750 x g), 
resuspended in lysis buffer (1% SDS, 2 mM EDTA, 32 mM NaOAc, pH 4.5), and vortexed 
vigorously.  After incubation on ice for 15 min, the lysate was cleared by centrifugation (10 min 
at 10,000 x g), extracted with acid-phenol chloroform (Ambion) until the organic-aqueous 
interface was clear, and the aqueous layer was washed once with chloroform.  An equal volume 
of isopropanol was added to the resulting aqueous extract and the mixture was incubated on 
crushed dry ice 20-30 min prior to centrifugation (20 min, 15,000 x g).  The resulting pellet was 
dissolved in 50 mM NH4OAc, pH 4.5, and subjected to size-exclusion chromatography using 
NAP5 columns (GE Healthcare).  The macromolecular fraction was treated with 0.04 U/µL 
TURBO DNase (Ambion) at 25 ºC for 30 min and then with 0.06 U/µL proteinase K (New 
England Biolabs) at 25 °C for 30 min.  The resulting solution was extracted with acid-phenol 
chloroform (Ambion) twice, washed with chloroform, and again subjected to size-exclusion 
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chromatography using NAP5 columns.  The macromolecular fraction was divided into aliquots, 
lyophilized, and stored as a dry powder at -80 ºC. 
 
Nuclease Digestion.  The cleavage condition sample was prepared by incubating 500 µg of E. 
coli RNA or 500 µg of S. venezuelae RNA with 10 U nuclease P1 (Sigma-Aldrich) in 200 µL of 
50 mM NH4OAc, pH 4.5 at 37 ºC for 40 min.  The control condition samples was prepared by 
incubating 500 µg aliquot of E. coli RNA or S. venezuelae RNA with 10 U heat-inactivated 
nuclease P1 (95 ºC for one hour) in 200 µL of 50 mM NH4OAc, pH 4.5 at 37 ºC for 40 min.  The 
digestion products were purified by size-exclusion chromatography (NAP5) and the small-
molecule fraction was retained.  The nuclease P1 digestion with H218O (Cambridge Isotope 
Laboratories) was performed as described above except in buffer with a final composition 
containing 86% H218O and 14% H216O.   
LC/MS Data Collection and Analysis.  LC/MS was performed using a Waters Aquity UPLC 
Q-TOF Premier instrument with an Aquity UPLC BEH C18 column (1.7 µm, 2.1 mm x 100 mm, 
Waters).  Mobile phase A was 0.1% aqueous ammonium formate, and mobile phase B was 100% 
methanol.  The flow rate was a constant 0.300 mL/min and the mobile phase composition was as 
follows: 0% B for 3 min; linear increase over 17 min to 100% B; maintain at 100% B for 2 min 
before returning linearly to 0 % B over 1 min.  Electrospray ionization (ESI) was used, with a 
capillary voltage of 3.5 kV, sampling cone voltage of 40.0 kV, and collision voltage of 1.0 eV.  
The drying gas temperature was 300 ºC, the drying gas flow rate was 800 L/hour, the source 
temperature was 150 ºC, and the detector was operated in negative ion mode.  To observe the 
NAD parent ion ([M-H]- m/z = 662.1018), the capillary voltage was 2.75 kV and the sampling 
cone voltage was 20.0 kV.  For each sample, 15 µL of the redissolved lyophilized material was 
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injected.  Ions with cleavage condition average integrated ion intensities below 50 ion counts 
were not considered for further analysis.  The XCMS program109 quantified the area under 
detected ion abundance peaks as it stepped through each ion chromatogram; the step size was set 
to 0.050 Da.  Integrated ion abundances were averaged among replicates, and the enrichment 
values reported were the ratios of these average ion intensities between active nuclease 
conditions and heat-inactivated nuclease (control) conditions. 
 
MS/MS Fragmentation Analysis.  MS/MS experiments were performed using the same 
instrument, LC gradient, and MS parameters described above.  The collision voltage was varied 
empirically from 20.0-30.0 2V. 
 
Isotope Labeling of S. venezuelae RNA.  S. venezuelae ATCC #10595 was cultured to OD600 = 
0.7-0.8 at 30 °C in minimal media (4.3 g/L NaH2PO4, 6.1 g/L K2HPO4, 2.0 g/L NaCl, 2.0 mg/L 
FeSO4·7H2O, 2.0 mg/L MnCl2·4H2O, 2.0 mg/L ZnSO4·7H2O, 2.0 mg/L CaCl2, 0.6 g/L 
MgSO4·7H2O, 10.0 g/L glucose, and 2.0 g/L (NH4)2SO4)140.  For 13C labeling, 13C-glucose (99% 
13C, Cambridge Isotope Laboratories) was used as the sole carbon source.  For 15N labeling, 15N-
ammonium sulfate (99% 15N, Cambridge Isotope Laboratories) was used as the sole nitrogen 
source.  RNA isolation, nuclease P1 digestion, and LC/MS analysis was performed as described 
above. 
 
NAD Spiking Into Cell Lysate.  E. coli TOP10 cell lysate was prepared as described above and 
divided into three equal aliquots.  NAD and NADH (Sigma-Aldrich) were added to the cell 
lysate as follows:  aliquot 1: no added NAD or NADH; aliquot 2: 500 nmol of NAD; aliquot 3: 
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500 nmol of NADH.  Based on our standard curve analysis 500 nmol of NADH or 500 nmol of 
NAD theoretically represents 4,000,000 ion counts; in practice, this amount of NAD or NADH 
saturates the detector.  Cell lysates were processed and analyzed as described above. 
 
RNase A Digestion.  Total RNA prepared as described above was subjected to digestion with 1 
µg RNase A (Ambion) in 200 µL of 50 mM NH4OAc, pH 4.5, at 37 ºC for 20 min).  After 
digestion, the sample was subjected to size-exclusion chromatography (NAP5, GE Healthcare) 
and the small-molecule fraction was lyophilized.  The lyophilized product was redissolved in 20 
µL of 0.1 % aqueous ammonium formate and analyzed by LC/MS as described above. 
 
Number of NAD-RNA(s) per E. coli cell.  To establish a standard curve of MS ion counts per 
pmol NAD, 5, 25, 50 and 100 pmols of authentic NAD (Sigma-Aldrich) were analyzed by initial 
and mild ionization conditions as described above.  The NAD signal from 500 µg of total E. coli 
RNA was compared to the standard curves to determine the number of pmols of cellular NAD 
per µg RNA.  The molecules of NAD-RNA per cell was then calculated based on 59x10-15 g 
RNA per E. coli cell.141 
 
Authentic NAD and NADH Carried Through Mock RNA Isolation.  To determine if cellular 
NADH-RNA could be detected by our nuclease based method, 50 pmol of NAD and NADH 
(Sigma-Aldrich) in 500 µL of 50 mM NH4OAc, pH 4.5 were incubated on ice for 15 min, and 
then at 4 °C for 10 min.  The samples were moved back to ice for 5 min and then placed at 4 °C 
for 10 min.  This procedure was repeated three times, corresponding to the number of acid-
phenol chloroform and chloroform extractions during the crude nucleic acid isolation.  The NAD 
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and NADH samples were then placed on crushed dry ice for 20-30 min prior to incubation at 4 
°C for 20 min, mimicking the isopropanol precipitation of cellular RNA.  While the crude 
nucleic acids were subjected to size-exclusion chromatography, the NAD and NADH samples 
were exposed to air and incubated at 25 °C for 10-15 min.  The samples were then incubated at 
25 °C for 1 h, and lyophilized.  The dry powder was redissolved in 200 µL of 50 mM NH4OAc, 
pH 4.5 and incubated at 37 ºC for 40 min.  The NAD and NADH samples were exposed to air 
and incubated at 25 ºC for 15-20 min.  The samples were lyophilized and stored as a dry powder 
at -20 ºC. 
 
Preparation of Authentic 5’-NAD-RNA.  5’-NAD-RNA was prepared as previously 
described.135  A DNA template containing the T7 class II promoter (Φ2.5) and encoding a 228-
base RNA was prepared by PCR.  Transcription was carried out in 1x New England Biolabs 
(NEB) RNA pol buffer supplemented with 1 mM each NTP, 1 mM NADH (Aldrich), 0.01% 
Triton X-100, 5 mM DTT, 0.2 U/µl RNase inhibitor (NEB), 0.2 µM DNA template, and 5 U/µL 
T7 RNA polymerase (NEB).  The reactions were incubated at 37 °C for 2 hrs before the product 
was isolated by precipitation with ethanol, dissolved in TURBO-DNase buffer (Ambion), and 
treated with TURBO-DNase (0.04 U/µL final concentration, 37 °C, 30 min).  The DNase-treated 
RNA was precipitated with ethanol, redissolved in water, and purified by size-exclusion 
chromatography (NAP5, GE Healthcare).  The precipitated NAD-RNA product following DNase 
treatment was dissolved in water, purified by silica column (Qiagen RNeasy), quantified by A260, 
digested with nuclease P1, and analyzed by LC/MS as described above in order to estimate the 
fraction of the resulting RNA strands that contained the NAD modification.  We observed that 
~3% of the transcripts generated by this procedure were linked to NAD. 
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In Vitro Transcription.  In vitro transcription reactions contained E. coli RNA polymerase 
(Epicentre Biotechnologies) in 50 mM Tris-HCl, pH 7.5; 150 mM KCl, 10 mM MgCl2, 0.01% 
Triton X-100 supplemented with NTPs (0.5 mM each), DTT (10 mM), and NADH (0.5 mM or 
5.0 mM).  The plasmid or genomic DNA template was added to a final concentration of 0.02 
µg/µL and E. coli RNA polymerase was added to a final concentration of 0.04 U/µL.  The 
reactions were incubated at 37 °C for 22 hrs before the product was isolated by precipitation with 
ethanol, dissolved in TURBO-DNase buffer (Ambion), and treated with TURBO-DNase 
(Ambion) at a final concentration of 0.04 U/µL for 30 minutes at 37 °C.  The RNA was purified 
by RNeasy spin-column (Qiagen) to remove free NTPs and NADH.  The resulting RNA was 
digested with nuclease P1 and analyzed by LC/MS as described above.  
The first template was a modified pUC19 plasmid, which encoded an adenosine at the +1 
position of each of its four predicted transcripts.  An in vitro transcription reaction containing 0.5 
mM of each NTP and either 0.5 mM or 5 mM of NADH yielded 222 µg or 174 µg of RNA, 
respectively.  The second template used was E. coli genomic DNA.  In vitro transcription in the 
presence of either 0.5 mM or 5 mM of NADH yielded 78 µg or 70 µg of RNA.  Once again, this 
material contained no detectable NAD or NADH after nuclease P1 digestion. 
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3.1 Introduction 
 We previously described the development of a nuclease-based screen that revealed NAD-
linked RNA.  Further characterization of NAD-linked RNA, including the size distribution and 
sequence, may elucidate its biological function.  A more comprehensive understanding can add 
to the known functional diversity of RNA and contribute to a greater insight of the RNA world.  
In this chapter, we will describe the progress toward the characterization of NAD-linked RNA. 
 
3.2 Size Distribution of NAD-Linked RNAs by Gel Electrophoresis 
 Size fractionation of total RNA followed by subsequent nuclease digestion and LC/MS 
analysis will yield the size distribution of small molecule-RNA conjugates.  Determining the 
distribution of sizes of the NAD-linked RNA will reveal if there is promiscuous incorporation of 
NAD modification on the 5’ end of total RNA or if there is localization of the modification to 
certain classes or size ranges of RNA.  If NAD signal is detected at a basal level in all of the size 
fractionation samples, then there may be non-specific incorporation of NAD by E. coli 
polymerase in vivo.  If NAD is found in only certain size ranges, then that may indicate the 
modification only exists on specific RNAs.  Therefore, knowing the size distribution of NAD-
linked RNA may yield insight into its biological function.  
Prior to nuclease P1 digestion, size-exclusion chromatography removes molecules of 
molecular weight less than ~2,500 Da.  To narrow the size window of NAD-linked RNAs and 
further fractionate the macromolecule fraction by size, we used silica-based RNA purification 
columns (Qiagen RNeasy columns).  The columns separate RNA molecules into two fractions 
that are less than or greater than ~200 nucleotides in length (Fig. 3.1a).  Each of the two fractions 
was then subjected to nuclease P1 digestion and LC/MS analysis. 
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Figure 3.1.  Silica column-based size fractionation of cellular RNA.  (a) Total E. coli or S. 
venezuelae RNA was separated into fraction I (RNAs of length greater than ~200 nucleotides) 
and fraction II (RNAs of length less than ~200 nucleotides) using a Qiagen RNeasy silica 
column.  The starting total RNA and each fraction (1 µg per lane) was analyzed by 1% TAE-
agarose gel electrophoresis and stained with ethidium bromide. (b) Total E. coli RNA was 
separated into RNAs of length greater than 200 nt (fraction 1) and RNAs of length less than 200 
nt (fraction II) using a silica column (Qiagen RNeasy).  Each fraction was subjected to nuclease 
P1 digestion and analyzed by LC/MS.  The presence of NAD in fraction II, similar to that of 
Phe-AMP, suggests that the NAD-linked RNA(s) are primarily less than 200 nt in length. 
 
 
The rRNA nucleoside modification N6,N6’-dimethyladenine (conjugated to 1.5 kB-2.9 kB 
rRNAs) was detected in the greater than 200 base fraction and 3’-aminoacyl adenosine 
monophosphates conjugated to tRNAs (~76 nucleotides) were present predominantly in the less 
than 200 nucleotide flow-through fraction, as expected (Fig. 3.1b).142,143  Like the tRNA 
modifications, the NAD-linked nucleotides were also predominantly detected in the flow-
through RNA fraction (Fig. 3.1b).  This result suggested that the NAD-linked RNA(s) from E. 
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coli and S. venezuelae are not widely distributed in their size but instead are below ~200 
nucleotides in length, as was also observed in the case of CoA-linked RNA from the same 
organisms.105  In addition, this finding further supported the hypothesis that the NAD 
modifications arise through a mechanism other than non-specific transcriptional initiation, which 
would be expected to generate a broad size distribution of NAD-linked RNAs. 
 
3.3 Size Distribution of NAD-Linked RNAs by High Performance Liquid Chromatography 
While the silica-based RNA purification columns were successful at separating total 
RNA into two fractions of greater than or less than 200 nucleotides in length, a finer resolution 
of NAD-linked RNA size would provide additional information.  Therefore, to identify more 
precisely the length(s) of NAD-RNA, we developed a method to size fractionate total RNA by 
high performance liquid chromatography (HPLC) using an anion-exchange column.  The method 
was first applied to a single-stranded RNA ladder of known lengths from 50 to 1000 nucleotides.  
The peaks could be separated by HPLC and gel electrophoresis detected bands of the appropriate 
sizes (Fig. 3.2a).  Thus, separation of a known ladder validated the method to fractionate RNA of 
different sizes.  We optimized the HPLC gradient for a wider range of oligonucleotide lengths 
and subjected total E. coli RNA to the protocol.  Similar to the RNA ladder, an increase in RNA 
lengths in subsequent HPLC fractions was observed by gel electrophoresis.  These results 
indicate that the HPLC method can size fractionate total RNA and that the quality of the RNA is 
preserved during the process (Fig. 3.2b). 
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Figure 3.2. Size fractionation of RNA by high performance liquid chromatography (HPLC). (a) 
An RNA ladder can be separated by HPLC and (b) total E. coli RNA can be separated by HPLC.  
Each HPLC peak was collected, concentrated and analyzed by 1% TAE-agarose gel 
electrophoresis and stained with ethidium bromide. 
 
To determine the size ranges of the NAD-linked RNAs, total RNA was subjected to the 
HPLC size fractionation protocol and five-minute fractions were collected during a 50-minute 
gradient.  Since the loading capacity of the HPLC column is 50 µg of total RNA and we required 
at least 250 µg of total RNA in order to detect NAD signal from NAD-linked RNA, we collected 
and combined samples from at least five HPLC runs.  The nucleic acids were concentrated and 
digested with nuclease P1 prior to LC/MS analysis. 
The presence of rRNA and tRNA modifications in the corresponding HPLC fractions was 
a positive control for successful HPLC size fractionation.  Indeed, rRNA modifications were 
detected in the 35 to 40 minute and 40 to 45 minute fractions and tRNA modifications and 
aminoacyl-adenylates in the five to ten minute fraction, as expected based on size information 
obtained from fractionation of the RNA ladder.  The NAD daughter ion signal was 
predominantly detected in the five to ten minute fraction, the same one as tRNAs (Fig. 3.3).  
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Based on the retention times of the RNA ladder peaks, these results suggested that NAD-linked 
RNA is in the 30 to 120 nucleotides size range.  This confirmed the previous silica-based column 
size fractionation result that NAD-RNA is less than 200 nucleotides long. 
 
Figure 3.3. NAD-linked RNA is detected in the five to ten minute HPLC fraction, suggesting 
they are between 30 and 120 nucleotides in length based on fractionation of a RNA ladder.  
Following size fractionation by HPLC, the samples are concentrated, digested with nuclease P1 
and analyzed by LC/MS. 
 
One concern from the size fractionation data is that NAD-linked RNA may be distributed 
across the entire HPLC gradient at a low level so NAD signal may be undetectable in individual 
fractions.  Since there is a decrease in overall signal before and after HPLC fractionation (due to 
material loss), the NAD signal in the five to ten minute sample may only be a portion of the 
complete NAD signal from total RNA.  To determine the fraction of NAD signal found in the 
2 3 4 5 6 7 8 9 10 11
0-5 min fraction
5-10 min fraction
10-15 min fraction
15-20 min fraction
20-25 min fraction
25-30 min fraction
30-35 min fraction
35-40 min fraction
40-45 min fraction
45-50 min fractionr
ela
tiv
e 
ab
un
da
nc
e 
of
 m
/z 
54
0.
05
 ±
0.
05
0
 74	  
five to ten minute fraction, the flow-through from the HPLC was collected, concentrated and 
digested prior to LC/MS analysis.  The majority (~80%) of the NAD signal was detected in the 
five to ten minute fraction so most of the NAD-linked RNAs were in the 30 to 120 nucleotides 
size range.  The NAD signal from samples that went through the HPLC size fractionation was 
also compared to a sample that did not go through the column to determine if there was 
significant loss of signal somewhere in the method and workup.  ~70% of the NAD signal was 
detected by LC/MS analysis after size fractionation compared with no fractionation.  This 
suggested that the RNA is not retained or stuck on the column after the HPLC size fractionation 
method is completed.  
The HPLC gradient was adjusted further to allow for greater separation of the less than 
200 nucleotide range from total RNA, focusing on the five to ten minute fraction where both 
NAD-linked RNA and tRNAs elute.  Interestingly, the tRNA modifications and aminoacyl-
adenylates continued to be detected in the same fraction as NAD-linked RNA.  This suggested 
that NAD-linked RNAs may be a similar length as the tRNAs (which are typically ~76 
nucleotides long).142,143 
 
3.4 Enrichment of NAD-Linked RNA by Oxime Formation 
An enrichment method to capture the small molecule-RNA conjugate for analysis is 
necessary in order to subject NAD-linked RNA to deep sequencing.  To enrich for NAD-linked 
RNAs from total RNA, we envisioned enzymatically introducing a reactive chemical substituent 
selectively onto the nicotinamide of the RNA, and using bioorthogonal chemistry to add a biotin 
handle onto the chemically-modified NAD.  The strong affinity of the biotin/streptavidin 
interaction will allow us to selectively pull out NAD-RNAs from the milieu of total RNA.144  
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After releasing the biotinylated NAD-RNA from the streptavidin, subsequent cloning and 
sequencing can be performed to determine the sequence(s) of NAD-RNA. 
ADP ribosylcyclase converts NAD into cyclic adenine dinucleotide phosphate ribose 
(cADPR) in vivo; however, it has been demonstrated to replace the nicotinamide on NAD for 
other 3’-substituted pyridines in vitro.145  To test the specificity of ADP ribosylcyclase, the four 
canonical nucleotides were subjected to the enzyme in the presence of 3’-
pyridinecarboxyaldehyde.  Each reaction contained the single nucleotide and the enzyme, or 
small molecule NAD and the enzyme.  After the reaction, the small molecules were analyzed by 
LC/MS.  Only the starting materials were detected in the reactions with the four canonical 
nucleotides and no products formed by an exchange reaction between the nucleotide bases and 
the 3’-pyridinecarboxyaldehyde were observed.  When NAD is present, only the exchange 
product after the reaction was detected.  To test that the enzyme is selective for NAD in a 
complex mixture, the nucleotides and NAD were pooled in one reaction.  Similar to the 
individual reactions, only the expected exchange product where the 3’-pyridinecarboxyaldehyde 
was substituted in the place of nicotinamide on NAD was observed, and the canonical 
nucleotides remained unchanged.  These experiments suggest that ADP ribosylcyclase is highly 
specific to exchanging the nicotinamide on NAD for 3’-substituted pyridines. 
In addition to its selectivity, ADP ribosylcyclase was also an attractive enzyme for 
introduction of a reactive handle on NAD-linked RNA since the reaction requires acidic 
conditions.  RNA is known to degrade under basic pH, where the rate is accelerated by stronger 
alkaline conditions that favor base catalysis.146  Therefore, acidic conditions will better preserve 
the quality of RNA so more intact nucleic acids can be subjected to deep sequencing. 
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Given the high selectivity of ADP ribosylcyclase to exchange only the nicotinamide on 
small molecule NAD for 3’-pyridinecarboxyaldehyde, we envisioned introducing a reactive 
pyridine onto the NAD-linked RNA, which would then form a bond with a biotinylated reagent.  
Of the possible reactions that are compatible with biomolecules, oxime formation seems 
particularly attractive since the reaction has fast kinetics (with the addition of aniline)147 and 
requires a low pH148,149 so RNA quality should be preserved.  Due to the more favorable reaction 
rates for the aldehyde compared with the ketone, we sought to use ADP ribosylcylase to 
exchange the nicotinamide with 3’-pyridinecarboxyaldehyde.145,147  Since carboxyaldehyde is 
isosteric to some of the other substituents on pyridines that have been successfully exchanged by 
ADP ribosylcylcase, we anticipated that 3’-pyridinecarboxyaldehyde might be accepted as a 
substrate for exchange.150  The crystal structure of the enzyme active site also shows room that 
may accommodate the RNA attachment to NAD.  After the reaction of NAD-linked RNA with 
3’-pyridinecarboxyaldehyde using ADP ribosylcyclase, introduction of biotin hydroxylamine to 
the aldehyde-exchanged NAD under oxime reaction conditions can incorporate biotin onto the 
NAD-RNA (Fig. 3.4). 
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Figure 3.4. The method to introduce a biotin group onto NAD-linked RNA using oxime 
formation for enrichment of NAD-RNA.  The nicotinamide is first exchanged for 3’- 
pyridinecarboxyaldehyde using ADP ribosylcyclase and then an oxime reaction is performed 
after introduction of a biotin hydroxylamine. 
 
The exchange reaction was performed with 3’-pyridinecarboxyaldehyde on the small 
molecule NAD, authentic 5’-NAD-linked transcript and total RNA in quantitative yield.  To 
monitor the reactions, the RNA was digested with nuclease and LC/MS analysis was conducted 
to scan for the desired nucleotide product (Fig. 3.5).  Upon introduction of the biotin 
hydroxylamine, all three examples underwent the oxime reaction yielding a biotin linked to 
NAD.  However, following the streptavidin pull-down, the desired NAD oxime product was not 
detectable in the elution.  Most of the signal was found in the unbound fraction, suggesting that 
the streptavidin is not capturing the biotin oxime-NAD product.  The incubation time for the 
RNA and streptavidin was increased, but the oxime product continued to be detected only in the 
flow-through. 
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Figure 3.5. Small molecule NAD, in vitro transcribed NAD-linked RNA and cellular NAD-
linked RNA can undergo the exchange reaction with 3’-pyridinecarboxyaldehyde and then an 
oxime reaction with biotin hydroxylamine. 
 
We hypothesized that there may be off-target reactions occurring during the oxime 
reaction.  If biotin from the hydroxylamine is incorporated nonspecifically on total RNA, the 
presence of all of the non-NAD-linked RNAs that are biotinylated may predominate the 
streptavidin binding.  Thus, given the percentage and length of NAD-linked RNA, the NAD 
signal is expected to be detected primarily in the flow-through.  
To test if hydroxylamine is reacting with more than just the aldehyde-exchanged NAD, 
we envisioned using a fluorescently-labeled hydroxylamine.  We hypothesized that upon the 
introduction of an Alexa Fluor hydroxylamine, pyridinecarboxyaldehyde-exchanged NAD-
linked RNA can form an oxime and gain a fluorescent tag (Fig. 3.6).  The small molecule NAD, 
5’-NAD-linked transcript and cellular RNA were subjected to the exchange and oxime reactions.  
The resulting nucleic acids were digested and analyzed by LC/MS, showing the expected 
exchange and oxime products in high yield.  The in vitro transcribed NAD-linked RNA and 
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cellular RNA samples were also analyzed by polyacrylamide gel electrophoresis.  As a negative 
control, the exchange reaction was omitted and the RNA was only subjected to the Alexa Fluor 
hydroxylamine under oxime reaction conditions.  We expected to observe bands that correspond 
to the exchanged NAD-RNA and no signal in the unexchanged negative control lanes when 
imaging for Alexa Fluor-linked RNA.  However, bands were detected in both sets of samples 
under the Alexa Fluor filter (Fig. 3.7), suggesting that there are off-target reactions occurring 
with the oxime formation. 
 
 
Figure 3.6. The method to add a fluorescent marker onto NAD-linked RNA for visualization of 
size distribution in total RNA.  The nicotinamide on NAD is first exchanged for 3’- 
pyridinecarboxyaldehyde and then an oxime reaction is performed after introduction of an Alexa 
Fluor hydroxylamine. 
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Figure 3.7. Oxime formation is not specific to reacting with the exchanged 3’-
pyridinecarboxyaldehyde on in vitro transcribed NAD-linked RNA or cellular RNA.  Lane 1: 
NEB low range ssRNA ladder, 2: in vitro transcribed 5’-NAD-linked RNA that was exchanged 
with 3’-pyridinecarboxyaldehyde, 3: in vitro transcribed 5’-NAD-linked RNA that was not 
exchanged with 3’-pyridinecarboxyaldehyde, 4: cellular RNA that was not exchanged with 3’-
pyridinecarboxyaldehyde, 5: cellular RNA that was exchanged with 3’-pyridinecarboxyaldehyde. 
 
To decrease unwanted reactions, the RNA was pre-blocked with hydroxylamine prior to 
the exchange reaction.  However, the unexchanged RNA continued to produce signal on the gel 
imaged with the Alexa Fluor filter.  The reaction time was decreased since we hypothesized that 
the aldehyde should be the most reactive group on RNA to the hydroxylamine and should form 
the oxime fastest.  The yield was much lower for the exchanged NAD-linked RNA and the 
unexchanged still showed detectable signal under the Alexa Fluor filter. 
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To investigate the scope of off-target reactions that were occurring, total RNA that had 
reacted with 3’-pyridinecarboxyaldehyde and ADP ribosycyclase were subjected to biotin 
hydroxylamine under oxime formation conditions.  As a negative control, total RNA that did not 
go through the exchange reaction was treated to the same oxime reaction conditions.  Both 
sample were digested with nuclease and subjected to LC/MS analysis.  Afterward, the data was 
processed by XCMS analysis to identify species that were enriched in the total RNA subjected to 
the exchange reaction compared with total RNA that had not gone through the exchange 
reaction.  If the biotin hydroxylamine reacted specifically with the aldehyde on the exchanged 
NAD-linked RNA, there should only be one compound that is enriched.  However, dozens of 
species appeared in both the unexchanged and exchanged reactions with hydroxylamine, so we 
started investigating other reactions that may react more specifically with the exchanged 5’-
NAD-linked RNA. 
 
3.5 Enrichment of NAD-Linked RNA by Click Chemistry 
Of the other possible reactions that are compatible with biomolecules, the 1,3-dipolar 
cycloaddition or “click” reaction is especially favorable due to its compatibility with a wide 
range of functional groups, fast kinetics, and water solubility.148,149  We envisioned exchanging 
the nicotinamide on NAD with an alkyne-substituted pyridine, which would be one of the click 
reaction partners. 
Even though 3’-ethynylpyridine has not previously been shown as a substrate that ADP 
ribosylcyclase will accept to exchange the nicotinamide with, the crystal structure of the enzyme 
active site shows room for slight promiscuity so the exchange reaction might install an alkyne 
onto NAD.150  A biotin azide can then be introduced to the EP-exchanged NAD-RNA, and in the 
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presence of copper, the two reagents should form a triazole, covalently linking the biotin to the 
NAD-RNA (Fig. 3.8). 
 
Figure 3.8. The method to add a biotin group onto NAD-linked RNA using click chemistry for 
enrichment of NAD-RNA.  The nicotinamide is first exchanged for 3’-ethynylpyridine and then 
a click reaction is performed after introduction of a biotin azide. 
 
The small molecule NAD, a 5’-NAD-linked transcript (generated in vitro using T7 RNA 
polymerase) and cellular RNA all performed the 3’-ethynylpyridine exchange reaction in 
quantitative yield.  To monitor the reactions, the RNA was digested with nuclease, analyzed by 
LC/MS, and scanned for the presence of the desired nucleotide product.  Upon exposure of a 
biotin azide, copper and ligand to the alkyne, the ethynylpyridine-exchanged small molecule and 
authentic NAD-linked RNA underwent click chemistry to produce a biotinylated 
ethynylpyridine-NAD.  However, despite significant efforts to optimize the reaction for total 
RNA, the click products on total RNA was not reproducibly observable.  Many conditions were 
screened, including CuSO4 and ascorbic acid,151,152 as well as Cu(I) without a reductant in the 
reaction (Figs. 3.9 and 3.10).153,154  The 3’-ethynylpyridine-exchanged small molecule and NAD-
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RNA showed the desired click products, but ethynylpyridine-exchanged total RNA only revealed 
the starting material.  Furthermore, addition of in vitro generated ethynylpyridine-exchanged 
NAD-RNA into total RNA under click reaction conditions also did not yield product. 
These results collectively indicate that there is something specific to the biological 
samples that inhibits the click reaction.  We hypothesized that the total RNA may be 
sequestering the copper.  Therefore, the concentration of the copper was increased, the 
concentration of RNA was decreased, and DMSO was added into the reaction to abrogate 
secondary structures.  Unfortunately, none of these conditions produced the desired click product 
in the total RNA case, whereas the small molecule and authentic NAD-RNA transcript showed 
the biotinylated ethynylpyridine-NAD in all conditions. 
 
NAD 
(µM, from RNA) biotin (µM) CuSO4 (µM) THPTA (µM) ascorbic acid (µM) 
1 50 50 250 2500 
0.5 50 50 250 2500 
0.2 10 10 50 500 
0.1 10 10 50 500 
0.1 5 5 25 250 
0.05 5 5 25 250 
1 500 1000 2000 5000 
0.2 100 200 400 1000 
0.1 50 100 200 500 
0.5 500 1000 2000 5000 
0.1 100 200 400 1000 
0.05 50 100 200 500 
1 5000 10000 20000 5000 
0.5 5000 10000 20000 5000 
0.5 5000 10000 10000 50000 
 
Figure 3.9. The click conditions attempted on small molecule NAD, in vitro transcribed NAD-
linked RNA and cellular RNA with 10 mM PBS, pH 7.8 as the buffer. 
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NAD (µM, from RNA) biotin (µM) CuBr (µM) THTA (µM) DMSO (%) 
0.5 500 1000 2000 5 
0.5 500 1000 2000 10 
0.1 100 200 400 10 
0.05 50 100 200 10 
0.2 100 200 400 10 
0.1 50 100 200 10 
0.5 500 1000 2000 50 
 
Figure 3.10. The click conditions attempted on small molecule NAD, in vitro transcribed NAD-
linked RNA and cellular RNA with 100 mM Tris-HCl, pH 8.0 as the buffer. 
 
Through personal communication with Professor Subha Das from Carnegie Mellon who 
developed a protocol to perform click chemistry on the 5’ end of RNA,155 we learned that the 
traditional click ligands could inhibit the reaction in RNA.  Acetonitrile was recommended as an 
alternative ligand to tris(hydroxypropyl)triazolylmethyl-amine (THPTA) and tris-
(Benzyltriazolylmethyl)amine (TBTA).  When acetonitrile was substituted for THPTA under 
click conditions, the exchanged small molecule NAD, authentic 5’-NAD-linked transcript and 
total RNA all produced the desired biotinylated NAD click product (Fig. 3.11).  Yet, gel 
electrophoresis showed degradation of the authentic 5’-NAD-linked transcript and total RNA 
after the reaction.  Degassing the solutions and decreasing reaction times did not significantly 
decrease the extent of RNA degradation as assessed by gel electrophoresis.  However, since 
biotinylated NAD signal was still detectable after precipitation, we hypothesized that NAD-RNA 
remain a length that could be used for sequencing. 
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Figure 3.11. LC/MS spectra of m/z 540.05 after the exchange, click and streptavidin elution 
reactions showing successful product formation in high yield. 
 
3.6 Enrichment of NAD-Linked RNA by Heck Reaction 
 The 1,3-dipolar cycloaddition or “click” reaction to specifically install a biotin group on 
the NAD-RNA results in degradation of total RNA, as observed by gel electrophoresis.  While 
the NAD-linked RNA may still be intact enough to be accessible for adapter ligation and deep 
sequencing, we were interested in other reactions that could incorporate biotin onto NAD-RNA 
and preserve the RNA integrity.  Professor Andrew Myers and coworkers had previously 
synthesized a biotin arylpalladium(II) trifluoroacetate complex that was used as a Heck coupling 
reagent to isolate the known protein targets of a series of natural products in affinity-isolation 
experiments (personal communication).  This reagent allows biotin to be coupled to compounds 
containing a vinyl substituent under mild aqueous conditions. 
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To attach biotin to NAD-RNA conjugates, we envisioned first using ADP 
ribosylcyclase145 to exchange the nicotinamide on NAD with 3’-vinylpyridine, which can be a 
Heck reaction partner, then exposing the resulting conjugate to the Myers biotin 
arylpalladium(II) reagent to attach biotin (Fig. 3.12).  The vinylpyridine-exchange reaction was 
successfully performed on the small molecule NAD, an in vitro generated 5’-NAD-linked 
transcript, and NAD-RNA conjugates contained in isolated cellular RNA.  In all three cases, 
LC/MS confirmed the presence of the expected modified nucleotide product.  Upon exposure to 
the Myers biotin arylpalladium(II) reagent, the vinylpyridine-exchanged small molecule NAD, in 
vitro-transcribed NAD-RNA and total RNA all underwent Heck coupling chemistry to produce a 
biotinylated vinylpyridine-NAD.  
 
Figure 3.12. The method to add a biotin group onto NAD-linked RNA using the Heck reaction 
for enrichment of NAD-RNA.  The nicotinamide is first exchanged for 3’-vinylpyridine and then 
a Heck reaction is performed after introduction of a biotin arylpalladium(II) trifluoroacetate 
complex. 
 
The Myers lab reported that they achieved an average yield of ~50% conversion of 
vinylpyridine to biotinylated product in their cell lysate system (personal communication).  The 
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reaction conditions were adjusted to optimize product yield, resulting in ~80 % of the expected 
product by LC/MS analysis.  However, the reaction required almost an entire day, allowing for 
the potential of RNA degradation.  Yet, under the two best reaction conditions (Fig. 3.13a), total 
RNA remained intact after both the vinylpyridine exchange and Heck coupling (Fig. 3.13b). 
Figure 3.13. Total RNA can undergo the exchange reaction with 3’-vinylpyridine and the Heck 
coupling to product biotinylated product while maintaining integrity.  (a) Total RNA was 
subjected to the exchange reaction with 3’-vinylpyridine and then the Heck reaction under two 
different buffer conditions.  Nuclease digestion and LC/MS analysis followed, and the extracted 
ion chromatogram is reported.  (b) Agarose gel electrophoresis of total RNA following the 
exchange reaction with 3’-vinylpyridine and the Heck reaction under two different buffer 
conditions showed that total RNA integrity is preserved during both reactions. 
 
3.7 Development of Adapter Ligation Protocol for Illumina Deep Sequencing 
The small RNA Illumina protocol guided the sequencing of the RNA(s) to which the 
small molecule is attached (Fig. 3.14).  Total RNA was first treated with tobacco acid 
pyrophosphatase, which typically hydrolyzes the phosphoric acid anhydride bonds in the 
triphosphate bridge of the cap structure found in most eukaryotic mRNA, releasing the cap 
nucleoside and generating a 5´-monophosphorylated terminus on the RNA molecule.156  The 
phosphatase also digests the triphosphate group at the 5´ end of prokaryotic transcripts, 
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generating an RNA molecule with a 5´-monophosphorylated terminus.  We discovered that 
tobacco acid pyrophosphatase also acts on NAD-linked RNA that had undergone the exchange 
and click or Heck reactions to cleave the biotinylated substituent and revealing 5’ 
monophosphates.  Following preparation of the 5’ end of RNA for ligation, the 3’ adapter was 
added and then the 5’ adapter using T4 RNA ligase I.  After adapter ligation, reverse 
transcription and PCR amplified only the transcripts that contain both adapters. 
 
Figure 3.14. The general method to add adapters onto small RNA for Illumina deep sequencing, 
beginning with treatment of total RNA with tobacco acid pyrophosphatase followed by 3’ and 5’ 
adapter ligation.  Reverse transcription and PCR will only amplify the RNAs containing both of 
the adapters. 
 
To test the protocol, a 5’-NAD-linked transcript, generated in vitro using T7 RNA 
polymerase, was subjected to each of the steps.  However, adapter ligation to the 228-mer 
template was not observed despite optimization of all of the reaction components.  Instead, only 
the amplified 5’ and 3’ adapters ligation product was detected.  When the positive control NAD-
linked transcript was submitted to IDT’s UNAFold program, the template was found to have a 
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high degree of secondary structure overall (Fig. 3.15).  Specifically, the region near the 5’ and 3’ 
ends contain multiple stem loops, which might prevent adapter ligation from proceeding. 
 
Figure 3.15. The secondary structure of in vitro generated 5’-NAD-linked RNA based on IDT 
UNAFold modeling suggesting that the 5’ and 3’ ends may be prevented from adapter ligation. 
 
To generate a better positive control, the template was shortened to a 50-mer (Fig. 3.16) 
and submitted to the Illumina adapter ligation protocol (Fig. 3.14)  This resulted in successful 
adapter ligation to the 50-mer template.  However, the predominant product detected was the 
result from the amplification of the 5’ and 3’ adapters ligated to each together.  To reduce the 
amount of ligated adapters present prior to sequencing, the cloning protocol was adjusted.  
Several iterations and optimization of the procedure resulted in the following protocol (Fig. 
3.17).  After the 3’ adapter ligation, the reverse transcription primer was introduced to allow for 
hybridization to both the ligated and excess 3’ adapter.  Then, the 5’ adapter ligation reaction 
was performed.  Since T4 RNA ligase I only ligates single stranded nucleic acids, excess 3’ 
adapter will not be accessible for ligation to the 5’ adapter if the reverse transcription primer is 
hybridized.  This prevented most of the unwanted 5’ and 3’ adapter ligations.  Furthermore, gel 
purification following adapter ligation and PCR amplification ensured that the desired ligation 
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containing total RNA is the predominant product.  The 50-mer RNA was subjected to each of 
these steps and the desired product without contamination was detected after PCR. 
 
Figure 3.16. The secondary structure of a 50-mer RNA using IDT UNAFold modeling program 
suggesting the RNA may engage in adapter ligation. 
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Figure 3.17. The modified cloning scheme to avoid adapter-adapter dimer formation for 
Illumina deep sequencing.  After tobacco acid pyrophosphatase treatment and 3’ adapter ligation, 
the reverse transcription primer is hybridized to the ligated and excess 3’ adapter.  5’ adapter 
ligation will only ligate onto single stranded nucleic acids, avoiding the undesired adapter-
adapter dimer ligation.  Reverse transcription and PCR should amplify just the desired ligation 
products. 
 
3.8 Application of Adapter Ligation Protocol to Cellular RNA 
E. coli total RNA samples was taken through the enrichment and modified adapter 
ligation protocols (Fig. 3.17) in preparation for Illumina high-throughput sequencing.  The ADP 
ribosylcyclase-catalyzed exchange reaction was performed with either 3’-ethynylpyridine or 3’-
vinylpyridine, and then biotin azide or the biotin arylpalladium(II) trifluoroacetate complex was 
introduced to attach biotin onto NAD-RNA (Fig. 3.18).  Samples that did not go through the 
exchange reaction or the click or Heck reactions were prepared as negative controls.  A portion 
of those samples was enriched by streptavidin pull-down.  All of the comparative samples were 
treated with tobacco acid pyrophosphatase and taken through the adapter ligation protocol.  A 
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barcode was included on the 3’-end of the 5’ adapter for multiplexing purposes.  Two biological 
replicates was subjected to each of these steps and submitted for Illumina deep sequencing. 
Name Exchange? Biotinylation? Streptavidin? Barcode 
Click_Pre + + - Mult1 
Click_Post + + + Mult2 
Heck_Pre + + - Mult1 
Heck_Post + + + Mult2 
EC click - + - Mult1 
EP elute + - + Mult2 
E + - - N6 
EC heck - + - Mult1 
VP elute + - + Mult2 
V + - - N6 
 
Figure 3.18. E. coli total RNA was subjected to different combinations of the exchange, 
biotinylation or streptavidin reactions to prepare comparative samples for Illumina deep 
sequencing. 
 
3.9 Computation Analysis of Illumina Deep Sequencing Data Using the Tuxedo Platform 
About 200 million reads was obtained from each lane containing comparative total RNA 
samples (Fig. 3.19).  The sequences were subjected to the Tuxedo protocol157 for alignment to 
the genome and identification of transcripts that are enriched following streptavidin pull-down.  
Prior to removing the barcodes, a very small percentage of the sequences aligned to the E. coli 
genome, as expected (Fig. 3.19). 
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Name Number of Reads (Unfiltered) 
% mapped to genome 
(unfiltered) 
Number of Reads 
(filtered) 
% mapped to 
genome (filtered) 
Click1_Pre 101,306,061 0.37616999 38,240,355 37.74735156 
Click1_Post 114,709,178 0.103256777 24,397,901 21.26935388 
Click2_Pre 79,149,392 0.311062402 n/a n/a 
Click2_Post 103,375,261 0.131809099 n/a n/a 
Heck1_Pre 110,045,635 13.71993446 68,733,454 62.45904619 
Heck1_Post 109,692,614 16.5774434 109,472,932 99.79972945 
Heck2_Pre 111,876,426 12.32193367 81,261,175 72.63476132 
Heck2_Post 154,514,760 19.77578551 103,286,633 66.8458036 
EC1 click 101,918,771 5.530599461 n/a n/a 
EP1 elute 85,588,136 0.600056298 n/a n/a 
E1 46,927,860 5.112941438 n/a n/a 
EC2 click 107,863,347 3.567114416 25,058,904 23.23208457 
EP2 elute 90,809,759 0.836596208 71,628,793 78.87785827 
E2 35,095,837 6.392863632 19,466,219 55.46589187 
EC1 heck 118,180,825 24.20982078 92,829,890 78.54902858 
VP1 elute 100,515,355 10.12773111 98,573,243 98.06784546 
V1 38,155,896 7.821145125 22,830,824 59.83563851 
 
Figure 3.19. Data from Illumina deep sequencing of total RNA comparative samples using the 
Tuxedo platform. 
 
After barcode removal, the sequences were mapped to the E. coli genome using TopHat, 
an alignment program for RNA-Seq reads.  TopHat is built on the mapping program Bowtie, 
which aligns large sets of short DNA sequences to genomes, and is often used for processing 
sequences from Illumina Hi-Seq experiments.158  While Bowtie cannot align reads to the genome 
that contain large gaps, TopHat solves this problem by breaking up reads that Bowtie cannot 
align on its own into smaller pieces, which can typically be aligned to the genome.  Reads that 
align outside annotated genes are often strong evidence of new noncoding RNAs and protein-
coding genes.157  Alignments can also be used to accurately quantify gene and transcript 
expression, because the number of reads produced by a transcript is proportional to its 
abundance.  Thus, the read densities can be used to measure transcript expression. 
We mapped the biological replicates independently using TopHat, for more accurate 
statistical analysis.  On average, about 62% of the sequences from samples that went through the 
exchange and corresponding click or Heck reactions aligned to the genome after barcode 
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removal.  Sequences had to be longer than twelve bases with at most two mismatches in order to 
be counted as aligning to the genome.  Unfortunately, TopHat was not able to process two of the 
Illumina sequencing lanes, which contained the second biological replicate of the click reaction 
and a replicate of the negative control with the click reaction. 
Following sequence alignment to the genome, the abundance of transcripts between pre 
and post streptavidin was compared using the rest of the Tuxedo platform.  The mapped reads 
from TopHat are provided as input to Cufflinks, a tool for transcriptome assembly and isoform 
quantitation from RNA-seq experiments.  Cufflinks is a program that assembles aligned RNA-
Seq reads into transcripts, estimates their abundances, and tests for differential expression and 
regulation transcriptome-wide for each replicate.159  These assemblies are then merged with the 
reference transcriptome annotation into a unified annotation using Cuffmerge for further 
analysis.  This merged assembly provides a uniform basis for calculating gene and transcript 
expression in each condition.  The reads and the merged assembly are introduced to Cuffdiff, 
which calculates expression levels in two or more samples and tests the statistical significance of 
each observed change in expression between them.157 
The Tuxedo platform should be able to identify transcripts that are enriched in the post-
streptavidin pull-down samples compared with the pre-streptavidin samples, identifying possible 
candidates of RNA sequences that contain a 5’ NAD modification.  This analysis yielded 71 
transcripts that are more than ten-fold enriched comparing before and after streptavidin pull-
down.  All of the enriched sequences are greater than 200 nucleotides in length and are from 
coding RNA.  If one or all of the transcripts contain NAD on the 5’ end, there is likely further 
processing of the transcript to end with a final product of NAD-linked RNA that is shorter than 
200 nucleotides, as determined by our previous experiments. 
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Taking into account the enrichment and abundance following the streptavidin pull-down, 
the top three candidates for containing a 5’ NAD on the transcript are the cca, adk and thrA 
transcripts (Fig. 3.20).  The cca protein catalyzes the addition and repair of the essential 3'-
terminal CCA sequence in tRNAs.  Adenylate kinase (adk) is an essential enzyme that recycles 
AMP in active cells, converting ATP and AMP to two molecules of ADP and vice versa.  The 
thrA protein has not been extensively characterized, but based on homology, it is predicted to 
have phosphatase activity. 
Genome position Pre-streptavidin 
counts 
Post-streptavidin 
counts 
Fold change Protein Function 
(putative) 
3313675-3314914 40.85 8018.06 196.26 
 
catalyzes the addition and 
repair of the essential                      
3'-terminal CCA sequence 
in tRNAs  
564415-565060 
 
1132.5 
 
41721.3 
 
36.84 
 
essential enzyme that 
recycles AMP in active 
cells;                      converts 
ATP and AMP to two 
molecules of ADP 
4277857-4280743 
 
216.62 
 
7362.96 
 
33.99 phosphatase 
 
Figure 3.20. The top three enriched transcripts that should contain 5’-NAD-linked RNA based 
on the Tuxedo platform processing. 
 
Antisense pull-downs were performed to verify if the identified RNA sequences contain 
NAD on the 5’ end of the transcript.  Antisense oligonucleotides were synthesized to different 
portions of the gene and cellular RNA was incubated with the probes.  Given that the Tuxedo 
platform identifies entire transcripts that are enriched instead of the portions of transcripts that 
are enriched, probes were designed to cover entirely the identified transcripts for pull-down.  The 
probes were spaced about two hundred nucleotides apart, and total RNA was incubated with 
each individual probe, as well as all of the probes for one transcript.  Following release of the 
cellular RNA, nuclease P1 digestion and LC/MS analysis, NAD signal was not detected on the 
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pull-down transcripts.  To confirm that the desired transcript was enriched, reverse-
transcription/PCR was performed on the eluted material.  Furthermore, to make sure that the 
NAD signal from a transcript is not being lost through the sample preparation, a probe to an in 
vitro generated 5’-NAD-linked transcript was designed, synthesized, and subjected to a pull-
down.  Following nuclease digestion and LC/MS analysis, NAD signal was detected only in the 
elution sample, and not in the unbound fraction.  Taken together these results suggest that the 
transcripts we had identified using the Tuxedo platform do not contain NAD on their 5’ end. 
Comparison of the intensity of the signal from an individual NAD-linked RNA sequence 
to the total NAD signal from cellular RNA coupled with the pull-down efficiency will yield 
information about whether other sequences exist with the NAD modification.  Furthermore, the 
pull-down will reveal the percentage of a sequence that contains the NAD modification, which 
will be useful in better understanding the potential cellular functions of NAD-linked RNA. 
 
3.10 Reasons Why Cufflinks Did Not Accurately Identify NAD-Linked RNAs 
While Cufflinks is capable of processing single-end RNA-Seq reads, the algorithms for 
transcript assembly and expression quantitation are much more accurate with paired-end reads.157 
The assembly algorithm explicitly handles paired end reads by treating the alignment for a given 
pair as a single object in the covering relation.  This could distort the calculations, resulting in 
false positive identification of transcripts that are enriched in the post-streptavidin samples 
compared with the pre-streptavidin samples. 
Sequencing read length is also a major consideration, and longer reads are generally 
preferable to short ones.  Since NAD-linked RNA are in the 30 to 120 nucleotide length, a 50 bp 
read length should have been adequate.  However, TopHat is more accurate when discovering 
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splice junctions with longer reads, and reads of 75 bp and longer are substantially more powerful 
than shorter reads.157  The read length of our samples may have affected the higher than normal 
false positive rate in the computational processing. 
 
3.11 Computation Analysis of Illumina Deep Sequencing Data Using Alternate Method 
While the Tuxedo platform is relatively user friendly and readily available, the 
algorithms only calculate differential expression of entire transcripts.  TopHat aligns the Illumina 
sequences to the genome and then Cufflinks/Cuffdiff identifies transcripts that are enriched from 
one sample to another.  The algorithms do not identify the distribution of sequences within a 
transcript.  However, since NAD-linked RNA may be a portion or a processed form of a 
transcript, a finer resolution than the entire transcript would be optimal. 
To process the Illumina deep sequencing data independently from the previous method, 
the barcodes were removed using the FastX program.  The parameters allowed for up to four 
mismatches in the barcode sequence and up to four shifts in order to achieve a partial match.  
The sequence length needed to be greater than ten bases for genome alignment.  The short read 
aligner bwa was used to align the filtered reads to the E. coli reference genome K-12 MG1655 
strain.  As expected, the percentage of sequences that aligned to the genome after removing the 
barcode greatly increased (Fig. 3.21). 
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Name Number of Reads (Unfiltered) 
% mapped to genome 
(unfiltered) 
Number of Reads 
(filtered) 
% mapped to 
genome (filtered) 
Click1_Pre 101,306,061 0.37616999 42,475,587 46.08437747 
Click1_Post 114,709,178 0.103256777 58,840,050 44.6392607 
Click2_Pre 79,149,392 0.311062402 40,971,529 50.9648814 
Click2_Post 103,375,261 0.131809099 63,335,360 44.63335595 
Heck1_Pre 110,045,635 13.71993446 58,383,099 36.1482641 
Heck1_Post 109,692,614 16.5774434 85,139,089 30.85180869 
Heck2_Pre 111,876,426 12.32193367 54,654,121 41.50623495 
Heck2_Post 103,286,633 19.77578551 80,777,632 34.68182525 
EC1 click 101,918,771 5.530599461 32,797,198 53.6578291 
EP1 elute 85,588,136 0.600056298 47,218,985 48.96858981 
E1 46,927,860 5.112941438 30,848,895 71.14651125 
EC2 click 107,863,347 3.567114416 36,387,897 52.96607001 
EP2 elute 90,809,759 0.836596208 47,251,012 54.94738906 
E2 35,095,837 6.392863632 23,692,258 72.05784384 
EC1 heck 92,829,890 24.20982078 66,659,883 52.90912577 
VP1 elute 98,573,243 10.12773111 51,553,451 32.28392732 
V1 38,155,896 7.821145125 25,703,747 69.16131992 
 
Figure 3.21. Data from total RNA comparative samples using an alternate method to the Tuxedo 
platform. 
 
Instead of using the Tuxedo platform for genome alignment and enrichment calculation 
based on transcripts, the sequences can first be aligned to each other, and then the enrichment 
can be calculated on a nucleotide resolution.  The number of reads covering each base was 
counted, and then for each base, the counts of the 50 bases around it were summed.  Finally, the 
fold-change difference was calculated for every tenth base.  Since there were two biological 
replicates for each sample, the two replicates of the post-streptavidin samples were averaged and 
divided by the averages of the pre-streptavidin samples.  For example, the average of the signal 
from the two click reactions that had gone through streptavidin pull-down were compared with 
the average of the signal from the two click reactions that had not gone through the pull-down.  
The regions where at least three consecutive points is about a fold threshold were counted as 
enriched since the size fractionation data suggested that NAD-linked RNA is greater than 30 
nucleotides in length. 
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Using this method, 300 regions under the click reaction were enriched greater than 1.75-
fold between the post and pre pull-down samples.  30 regions were enriched in the click reaction 
if the threshold was restricted to greater than 2-fold.  For the Heck reaction, 952 regions were 
enriched greater than 1.75-fold and 372 regions were enriched greater than 2-fold.  The biggest 
fold changes are 2.5 for the click samples and 3.4 for the Heck reaction. 
 When the enriched click and Heck transcript regions were compared with one another, 
two sequences were found within 100 bases from each other (Fig. 3.22).  The two sequences are 
within transcripts that translate into a tRNA modification enzyme and a thiamin biosynthesis 
protein.  The trmE modification enzyme has a 1,365 nucleotides transcript and is involved in the 
biosynthesis of the hypermodified nucleoside 5-methylaminomethyl-2-thiouridine, which is 
found in the wobble position of some tRNAs and affects ribosomal frameshifting.  The enzyme 
is also involved in regulation of glutamate-dependent acid resistance.  The second shared 
enriched region is from the sulfur carrier protein ThiS transcript, which is 201 nucleotides in 
length.  This protein forms a complex with ThiF, ThiG, and ThiO to catalyze the formation of the 
thiazole moiety of thiamine pyrophosphate. 
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 Reaction Begin End 
Enrichment of Post-
Streptavidin/Pre-
Streptavidin 
Protein Function 
1 Heck 3,983,059 3,983,239 2.501 
 Click 3,982,959 3,982,989 1.940 
Biosynthesis of the 
hypermodified nucleoside                      
5-methylaminomethyl-2-
thiouridine, which is found in 
the wobble position of some 
tRNAs and affects ribosomal                      
frameshifting 
 
2 Heck 4,290,247 4,290,327 2.715 
 Click 4,290,252 4,290,292 1.858 
With ThiF, ThiG, and ThiO 
catalyzes the formation of the 
thiazole moiety of thiamine 
pyrophosphate 
 
 
Figure 3.22. Shared regions in the click and Heck enriched samples that should contain 5’-NAD-
linked RNA from the alternate method. 
 
Antisense probes were designed for the two regions and pull-downs were performed on 
total RNA to confirm the presence of NAD on the identified transcript regions.  After eluting 
from streptavidin and digesting with nuclease, LC/MS analysis showed no NAD signal in the 
elution fraction, while all of the expected NAD ion counts were present in the flow-through.  
This suggests that the two transcript regions predicted to contain the NAD modification did not 
have a detectable 5’-linked NAD.  A positive control for the pull-down was an antisense probe to 
an in vitro transcribed NAD-linked RNA.  LC/MS analysis following streptavidin elution and 
nuclease digestion showed NAD signal, suggesting that the pull-down and detection is working. 
If the shared window is widened to 1000 bases, there are nineteen transcripts that are 
enriched in both click and Heck greater than 1.75 fold.  The process of synthesizing biotinylated 
antisense probes to each of the shared enriched regions and performing the pull-downs is 
currently ongoing.  Similarly, we are continuing the investigation of whether the transcript 
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regions that are uniquely enriched in either the click or Heck reaction contain the NAD 
modification.  
 
3.12 Conclusions 
 Size fractionation of total RNA by silica-based columns that separate RNA greater than 
200 nucleotides from the smaller fraction revealed NAD-linked RNA in the less than 200 
nucleotides fraction.  For a finer resolution, we developed a method to size fractionate total RNA 
using an anion-exchange column and high performance liquid chromatography (HPLC).  
Application of this method to E. coli cellular RNA generated a data set that contains other small 
molecule-RNA conjugates in addition to the NAD modification.  Therefore, once researchers 
identify a novel small molecule-linked RNA, they can determine its sizes using the generated 
data allowing them to save time and reagents.  LC/MS analysis of the HPLC size fractionation 
samples revealed that NAD-linked RNA is between 30 to 120 nucleotides in length.  Both size 
fractionation methods resulted in a similar conclusion that NAD-linked RNA is of a similar size 
to tRNAs. 
 To enrich for NAD-linked RNA from a milieu of total RNA for deep sequencing, we 
developed methods that introduces a chemical handle onto NAD.  ADP ribosycyclase is a 
specific enzyme that will selectively exchange the nicotinamide for a variety of 3’-substituted 
pyridines in vitro.  The exchange reaction was performed to install a 3’-pyridinecarboxyaldehyde 
onto NAD-linked RNA.  Then, introduction of a biotin hydroxylamine under oxime reaction 
conditions installed a biotin group onto the exchanged NAD-linked RNA.  LC/MS analysis 
confirmed that the oxime reaction was successful at introducing a biotin group onto 3’-
pyridinecarboxyaldehyde exchanged NAD-linked RNA.  However, NAD-linked RNA was not 
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detectable after streptavidin elution.  Gel electrophoresis of an oxime reaction between Alexa 
Fluor hydroxylamine and the 3’-pyridinecarboxyaldehyde exchanged NAD-linked RNA revealed 
that there were non-specific reactions between the hydroxylamine and RNA.  Efforts to decrease 
or prevent the undesired reactions continued to result in NAD-linked RNA present in the flow-
through after streptavidin binding. 
 The click reaction was a possible alternative to the oxime formation.  We performed the 
exchange reaction with ADP ribosycyclase and 3’-ethynylpyridine, followed by introduction of 
biotin azide to install a biotin group onto NAD-linked RNA.  Despite successfully biotinylating 
small molecule NAD and in vitro generated NAD-linked RNA, initial efforts to perform click 
chemistry on total RNA were ineffective.  Screening of different conditions, including switching 
ligands, finally resulted in biotinylation of NAD-linked RNA in total RNA by the click reaction.  
However, while the desired biotinylated NAD was detectable after the click reaction and 
streptavidin binding and elution, gel electrophoresis revealed degradation of total RNA.  Since 
copper is known to degrade RNA, other methods of bioorthogonal chemistry that were available 
for incorporating a biotin group onto NAD-linked RNA were investigated. 
 The Heck reaction was previously used to biotinylate a protein in cell lysate (personal 
communication).  We subjected NAD-linked RNA to the exchange reaction with ADP 
ribosycyclase and 3’-vinylpyridine.  Following the exchange, a biotin arylpalladium(II) 
trifluoroacetate complex that added a biotin group onto NAD-linked RNA was introduced under 
Heck reaction conditions.  Reaction conditions were optimized to increase product yield, and 
despite the long reaction time of 23h, gel electrophoresis did not detect appreciable total RNA 
degradation. 
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 To prepare comparative total RNA samples for Illumina deep sequencing, adapter 
ligation methods were developed.  The main challenge to each of the attempted protocols was 
that the 5’ and 3’ adapters would ligate to each other and amplify more favorably than the 
samples containing total RNA ligated to the 5’ and 3’ adapters.  To solve this problem, we 
employed hybridization of the reverse transcription primer to the excess 3’ adapter prior to the 5’ 
adapter ligation since the T4 RNA ligase only joins single stranded nucleic acids.  This alteration 
coupled with gel purification was able to yield the desired total RNA ligated with the correct 
adapters as the predominant product.  The developed method was applied to comparative total 
RNA samples subjected to click and Heck reaction conditions for Illumina deep sequencing. 
 Analysis of the Illumina deep sequencing results was first conducted using the Tuxedo 
platform, which consists of a genome alignment and enrichment calculation.  The programs 
aligned the Illumina sequences to the E. coli genome and then counted the number of reads per 
transcript for all of the comparative samples.  Enrichment between post-streptavidin and pre-
streptavidin samples was calculated on a transcript level.  Three candidates were highly enriched 
in both click and Heck reactions based on this analysis, so biotinylated antisense probes were 
designed and synthesized for pull-downs on E. coli total RNA.  We did not observe NAD-linked 
RNA signal in the streptavidin elution fraction and only in the flow-through sample, suggesting 
that these three transcripts did not contain 5’-NAD-linked RNA. 
 When the pull-downs did not yield the expected NAD signal, another analysis 
independent of the Tuxedo platform was used.  This time, the sequences were first aligned to 
each other and the coverage of each nucleotide was counted.  The counts for every ten bases 
were summed, and the enrichment was calculated by dividing the average of the biological 
replicates of the post-streptavidin elution counts with the pre-streptavidin elution signal.  These 
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calculations resulted in two regions that were enriched in both click and Heck samples.  
However, pull-downs using antisense probes to those regions did not result in detection of NAD-
linked RNA in the elution fraction.  
 Efforts toward elucidating the sequence of NAD-linked RNA are currently ongoing.  The 
sequence can generate additional hypothesis about the biological function of the small molecule-
RNA conjugate, which may add to the functional diversity of RNA.  
 
3.13 Materials and Methods 
General.  Unless otherwise noted, all starting materials were obtained from commercial 
suppliers and were used without further purification. 
 
RNA Size Fractionation by Silica Spin-Column.  Total E. coli or S. venezuelae RNA was 
dissolved in 100 mM aqueous DTT and purified with Qiagen RNeasy kit (Qiagen) following the 
manufacturer’s instructions.  RNA from either the flow-through (less than ~200 nucleotides) or 
the eluted fraction (greater than ~200 nucleotides) was recovered by two consecutive 
precipitations with ethanol followed by desalting using NAP5 columns (GE Healthcare). 
 
Size fractionation by HPLC.  Size fractionation was performed using high performance liquid 
chromatography (HPLC, Agilent 1100) with an anion-exchange Dionex DNAPac PA200 
4x250mm analytical column.  Mobile phase A was 0.3M sodium perchlorate and mobile phase B 
was 20% acetonitrile in water.  The flow rate was a constant 1.2mL/min, temperature was 80 °C 
and the mobile phase composition was as follows: linear increase from 30% A to 70% A for 5 
min; linear increase over 35 min to 100% A; maintain at 100% A for 5 min before returning 
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linearly to 70% A over 2 min and then to 30% A over 3 min.  Detection was carried out at 260 
nm and 230 nm.  10ug of an RNA ladder (Ambion, Inc.) was injected to test the size 
fractionation method.  50ug of total RNA from E. coli was injected for each size fractionation 
run.  Fractions were collected every 5 min and aggregated from four to ten runs.  The first two 
fractions (0-5 min and 5-10 min) were concentrated using Millipore’s Centriprep Centrifugal 
Filter Unit with Ultracel-3 membrane (YM-3) and the rest of the fractions were concentrated 
using the Centriprep Centrifugal Filter Unit with Ultracel-10 membrane (YM-10) by 
centrifugation (3,000 x g) until the total volume was less than 1.5mL.  The retentate was 
lyophilized and ethanol precipitated prior to nuclease P1 digestion.  For the digestion, the RNA 
was incubated with 2 U nuclease P1 (Wako Chemicals USA, Inc.) in 200uL of 50 mM NH4OAc, 
pH 4.5 at 37 ºC for 40 min. The digestion products were purified by size-exclusion 
chromatography (NAP5, GE Healthcare) and the small-molecule fraction was retained.  The 
samples were resuspended in 18uL of milliQ water and injected for LC/MS analysis. 
 
Cyclase Reaction.  Nicotinamide was exchanged for 3’-substituted pyridine by incubating 2 mg 
of total RNA with 30 µL of 1M 3’-ethnylpyridine or 3’-vinylpyridine and 30uL of ADP 
ribosylcyclase (0.1-0.3U/uL) in 300 µL of 200 mM NH4OAc, pH 4.5 at rt for 2h.  The reaction 
was then extracted with acid-phenol chloroform (Ambion) twice, and the aqueous layer was 
washed once with chloroform.  The aqueous layer was ethanol precipitated and the resulting 
pellet was dissolved in 50 mM NH4OAc, pH 4.5, and subjected to size-exclusion 
chromatography using NAP5 columns (GE Healthcare). 
 
 106	  
Click Reaction.  Small molecule NAD, in vitro generated 5’-NAD-linked transcript or total 
RNA containing NAD-linked RNA was subjected to click conditions as described in Table 3.1 
and 3.2.  The reagents were added in the following order: water, biotin azide (Invitrogen), 
DMSO (if included), ligand (Sigma-Aldrich), copper, and ascorbic acid (if included).  After the 
reaction, the sample was ethanol precipitated, resuspended in water, and taken through size 
exclusion chromatography where the macromolecule fraction was collected. 
 
Heck Reaction.  Small molecule NAD, in vitro generated 5’-NAD-linked transcript or total 
RNA containing NAD-linked RNA was subjected to either Tris-HCl, pH 8 or PBS pH 7.8 as the 
buffer, with a final concentration of 0.1 mM biotinylated arylpalladium(II) complex (Fig. 3.23), 
2% DMSO and 0.1% Triton.  The reaction was sealed and incubated at rt for 1, 5, 11.5 and 23 h. 
 
Figure 3.23. The biotinylated arylpalladium(II) complex used for the Heck coupling reaction. 
 
Oxime Reaction.  Nicotinamide was exchanged for 3’-pyridinecarboxyaldehyde by incubating 2 
mg of total RNA with 2 µL of 3’-pyridinecarboxyaldehyde and 20 µL of ADP ribosylcyclase, 
0.1-0.3 U/uL (Sigma-Aldrich) in 200 µL of 200 mM NH4OAc, pH 4.5 at rt for 3h.  The reaction 
was then extracted with acid-phenol chloroform (Ambion) twice, and the aqueous layer was 
washed once with chloroform.  The aqueous layer was ethanol precipitated and the resulting 
pellet was dissolved in 95 µL of 100 mM anilinium acetate (made fresh prior to each reaction).  5 
µL of 1 M biotin hydroxylamine in water was added to the reaction and incubated at rt with 
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shaking for 3h.  The entire reaction was subjected to size-exclusion chromatography using NAP5 
columns (GE Healthcare) and the macrocmolecular fraction was retained.  For the 
polyacrylamide gel electrophoresis, Alexa Fluor hydroxylamine was substituted for biotin 
hydroxylamine.  The reactions were ethanol precipitated and resuspended in water.  A portion 
was loaded onto a 5% polyacrylamide gel and imaged using Typhoon Imager (GE Healthcare). 
 
Adapter Ligation for Illumina Sequencing.  10 µg of total RNA was treated with 10 U of 
Tobacco Acid Pyrophosphatase (TAP, Epicenter) in 1x TAP buffer for 3 h at 37 °C.  The sample 
was frozen and then lyophilized prior to resuspension in 1x T4 ssRNA ligase buffer, 1 µM 3’ 
adapter, 1 mM ATP, and 10 U T4 ssRNA ligase (NEB).  The reaction was incubated at 37 °C for 
1 h.  1 µL of 50 mM reverse transcription primer was added to the reaction mixture and the 
sample was heated at 75 °C for five min, 37 °C for 30 min and then 25 °C for 15 min.  With five 
minutes remaining in the previous incubation, heat the 5’-adapter (20 µM) at 70 °C for two 
minutes, then transfer to ice immediately.  The ligation mixture contains 5 µM 5’-adapter, in 
addition to 1 mM ATP, and 10 U T4 ssRNA ligase (NEB).  Incubate at 25 °C for 1 h.  Take 3 µL 
of the ligation mixture and add to 1 mM dNTPs, 1x M-MuLV reverse transcriptase buffer, 100 
mM DTT and 20 U of super RNase inhibitor (Ambion).  Heat the sample at 42 °C for two 
minutes.  Add 200 U of M-MuLV reverse transcriptase (NEB) and incubate at 42 °C for 1 h.  For 
PCR amplification, take the reverse transcription reaction and add to 1 mM forward primer, 1 
mM reverse primer, 1 mM dNTPs, 1x Phusion buffer and 2 U of Phusion DNA polymerase 
(Fermentas).  The reaction was thermocycled at 98 °C for 30 sec, and then the following for a 
total of 20 cycles: 98 °C for 10 sec, 60 °C for 30 sec, 72 °C for 15 sec, and then 72 °C for ten 
minutes and holding at 12 °C. 
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Adapters: 
Mult 1: GTTCAGAGTTCTACAGTCCGACGATCGATCGGAAGAGCACACGTNNNNNN 
Mult 2: GTTCAGAGTTCUACAGTCCGACGATCACACTCTTTCCCTACACGNNNNNN 
 
5' RNA Adapter    
5' GUUCAGAGUUCUACAGUCCGACGAUC   
 
3' RNA Adapter    
5' P-UCGUAUGCCGUCUUCUGCUUGUidT  
 
Samples in each lane for Illumina deep sequencing (Fig. 3.18) 
1. Click1_Pre/Click1_Post  mult1/mult2 
2. Click2_Pre/Click2_Post  mult1/mult2 
3. Heck1_Pre/Heck2_Post  mult1/mult2 
4. Heck2_Pre/Heck2_Post  mult1/mult2 
5. E1/ EP1 elute/ EC1 click  N6/mult2/mult1 
6. E2/EP2 elute/EC2 click  N6/mult2/mult1 
7. V1/VP1 elute/EC1 heck  N6/mult2/mult1 
 
RT Primer   
5' CAAGCAGAAGACGGCATACGA  
 
Small RNA PCR Primer 1   
5' CAAGCAGAAGACGGCATACGA   
 
Small RNA PCR Primer 2   
5' AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA   
 
Small RNA Sequencing Primer   
5' CGACAGGTTCAGAGTTCTACAGTCCGACGATC  
 
50-mer: 
AGCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGGCGTAATCATGGTCA 
 
228-mer 
AGGAGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACAT
AGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCA
AGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGA
TCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAA
A 
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Computational Analysis of Illumina Sequencing 
Barcode splitting.  Read sequences were generated per lane on a standard Illumina flowcell.  
Reads from each lane were separated using the following molecular barcodes: 
 
GATCGGAAGAGCACACGT 
ACACTCTTTCCCTACAC 
 
The FastX toolkit program fastx_barcode_splitter.pl was used with the given barcode sequences, 
with the parameters --mismatches 4 and --partial 4.  These parameters allow for up to 4 
mismatches in the barcode sequence and up to 4 shifts in order to achieve a partial match.  These 
parameters were chosen in order to increase sensitivity for identifying error-prone barcode 
fragments. 
 
Read filtering.  All read sequences were examined with the quality control program FastQC.  
Frequent artifactual sequences were identified and removed.  Specifically, the FastX toolkit 
program fastx_clipper was used to remove poly-A sequences and Illumina adapter sequences.  
The following sequences (or prefixes) were filtered: 
 
TCGTATGCCGTCTTCTGCTTGTT Illumina Small RNA Adapter 2 
GATCGGAAGAGCACACGT Illumina Multiplexing Adapter 1 
ACACTCTTTCCCTACACG Illumina Multiplexing Adapter 2 
 
Reads were then trimmed to remove any barcode sequence and the unique 6-bp fingerprint.  The 
trimming was accomplished with the FastX utility fastx_trimmer.  Reads smaller than 10-bp after 
this filtering were excluded from further analysis. 
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Read alignment.  Filtered reads were aligned to the E. coli reference genome, K-12 MG1655 
strain (NCBI accession NC_000913.2) using the short read aligner bwa.160  The default settings 
for short single-ended read alignment were used, with multi-threading mode enabled. 
 
Pileup.  Read alignments were converted into genome pileup files using the SAMtools utility 
suite.161  These files list the sequenced bases observed at each position of the reference genome.  
The samtools depth command was used to calculate the number of reads covering each base pair 
position in the E. coli genome for each sequenced dataset. 
 
Statistics.  A custom script was used to calculate the read coverage of 50-bp sliding windows, 
calculated in 10-bp intervals along the genome.  This computation was performed for each 
sequenced dataset.  Read coverage fold changes were calculated for each replicated condition 
and compared to the appropriate replicated control experiment.  For a given fold change 
threshold, contiguous regions (spaced 10-bp apart) of at least three significant segments were 
identified.  Regions surpassing a given threshold (either 1.75x or 2x) were identified for each 
experimental condition. 
 
FastX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/index.html) 
 
FastQC utility (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) 
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Chapter Four: 
 
The Cellular Roles of NAD-Linked RNA and Future Directions 
 
Ye Grace Chen, Aaron Leconte, David R Liu 
Aaron Leconte isolated total RNA from B. subtilis, E. aerogenes, V. fischeri, S. pombe and S. 
cerevisiae.  Ye Grace Chen conducted and analyzed all of the other experiments described. 
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4.1 Introduction 
 The development of a screen to find cellular small molecule-RNA conjugates has 
provided a platform for the discovery of novel RNA chemical modifications and biological roles. 
Further investigations into the cellular functions of NAD-linked RNA may add to the diversity of 
functional RNA.  In this chapter, we describe the current efforts toward characterizing the 
biological scope of NAD-RNAs and propose future directions for the continued expansion of 
novel RNA modifications and functional roles. 
 
4.2 Screen for NAD-Linked tRNAs 
 Previous experiments suggest that the abundance of NAD-linked RNA is about 3,000 
copies per E. coli cell, which is comparable to the copy number of charged tRNAs.  Additionally, 
NAD-linked RNAs are between 30 and 120 nucleotides in length, as suggested by size 
fractionation using HPLC.  Taken together, these results suggest that tRNAs may contain the 
NAD modification.  To test this hypothesis, biotinylated antisense probes were synthesized to 
individual tRNAs and incubated with cellular RNA.  After streptavidin pull-down, nuclease 
digestion and LC/MS analysis, NAD signal was not observed in the elution fraction.  Rather, the 
modification was only detected in the unbound and flow-through fraction.  Therefore, the 
individual tRNAs did not contain a 5’-linked NAD. 
We hypothesized that the NAD modification may be present on several or many different 
tRNAs, and the NAD signal from individual tRNA pull-down may be below detection limits.  To 
address this concern, all of the biotinylated oligonucleotides that are antisense to the tRNAs were 
pooled for the pull-down.  Again, NAD was not detected in the pull-down material and solely in 
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the flow-through.  The lack of detection of the NAD modification suggests that the modification 
is present on other RNAs that are in the 30 to 120 nucleotides size range that are not tRNAs. 
 
4.3 Detection of NAD-Linked RNA in Species Other Than E. coli and S. venezuelae 
Highly conserved sequences, structures and motifs are thought to have functional value 
since conservation suggests there was an evolutionary advantage to maintaining them.  
Mutations in a highly conserved region may lead to a non-viable form or a form that is 
eliminated through natural selection.  Alternatively, conservation may also be a result of 
convergent evolution, where there was an advantage to the cell for having the specific sequence, 
structure or motif over other versions.  If NAD-linked RNA is conserved across different species 
and domains of life, the small molecule-RNA conjugate could be a “molecule fossil” and of an 
ancient origin.  There may be important functional roles for the NAD-linked RNA if the 
conjugate is highly conserved. 
There could be conservation of the presence of NAD-linked RNA, the RNA sequence, 
and the RNA structure.  To determine whether NAD-linked RNA is present in species other than 
E. coli and S. venezuelae, we applied our nuclease-based screen to RNA from a variety of 
species.  Total RNA was isolated from B. subtilis, E. aerogenes, V. fischeri, S. pombe and S. 
cerevisiae, digested with nuclease and analyzed by LC/MS.  E. coli and bovine tRNA was also 
obtained from commercial sources.  Our methods revealed NAD-linked RNA in B. subtilis, V. 
fisheri and E. aerogenes, as well as in bovine tRNA. 
The existence of NAD-linked RNA in species spanning the bacteria kingdom and in 
mammalian tRNA suggests that the functional role of the small molecule-RNA conjugate may be 
common to many species.  We hypothesize that the functional role may be fundamental to 
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different organisms and a greater understanding of the phylogeny of NAD-linked RNA could 
inform our comprehension of its roles. 
Understanding sequence conversation is important for the study of sequence evolution 
and for the identification of functional regions of the genome.162  To compare RNA sequences 
containing a 5’-linked NAD, total RNA would be extracted from the species that have been 
identified as possessing NAD-linked RNA.  After enriching for the small molecule-RNA 
conjugate from total RNA, the RNA would be subjected to the adapter ligation scheme as 
described in Chapter 3.7.  The sample could be sequenced and comparative analysis would be 
conducted of NAD-linked RNA from different species. 
Sequence similarities serve as evidence for structural and functional conservation, as well 
as of the evolutionary relationships between the sequences.  Consequently, comparative analysis 
is the primary means by which functional elements are identified.  If portions of the NAD-linked 
RNA were identified to show high sequence conservation, those areas may be particularly 
important and necessary for the proper function of the small molecule-RNA conjugate. 
The secondary and tertiary structure of RNA has been shown to greatly influence RNA 
function.  Therefore, knowing the RNA structure will provide crucial insights into the way in 
which RNA works.  Structural analysis could be performed on NAD-linked RNA to determine if 
there are conserved motifs between different species even if there is not sequence homology.  
While producing RNA high-resolution structures by X-ray crystallography and NMR 
spectroscopy is one method to obtaining RNA structures, this process is often slow and 
laborious.  Several programs have been developed to analyze RNA sequences and predict the 
secondary and tertiary structures.163,164 
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mfold is a common tool used for secondary structure prediction of single-stranded nucleic 
acids.  A secondary structure describes the stems of RNA, building blocks that form when two 
complementary regions of the sequence base pair and adopt a double-helix structure.  Secondary 
structure can be derived from a sequence by using a combination of free-energy minimization 
and covariation analysis.163  Efficient algorithms for RNA secondary structure prediction using 
dynamic programming methods borrowed from sequence alignment can be applied to the NAD-
linked RNAs from different species.165,166 
Secondary structures of RNA provide enough structural constraint to model tertiary 
structures.164  Algorithms have been developed based on MC-fold and MC-Sym and a first-order 
object to represent nucleotide relationships in structured RNAs: the nucleotide cyclic motif 
(NCM).  Adjacent NCMs share common base pairs, a property providing enough base-pairing 
context information to derive an effective scoring function and making possible the use of the 
same algorithm for predicting secondary and tertiary structures.164  This program has been 
successful at predicting structures from a single sequence for fragments of up to approximately 
150 nucleotides.  Since NAD-linked RNAs has previously been shown to be less than 200 
nucleotides, and in fact are in the 30 to 120 nucleotides range in E. coli, the tertiary structure 
prediction algorithm seems optimal for our purposes.  Therefore, we can subject the sequences of 
NAD-linked RNAs to this algorithm in order to predict tertiary structures. 
Highly conserved RNAs are often required for basic cellular function.  Understanding the 
phylogenetic distribution of NAD-linked RNA in terms of its presence, sequence and structure 
will greatly contribute to our knowledge of the small molecule-RNA function. 
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4.4 Search for Biosynthetic Pathways Through Which NAD-Linked RNA Are Synthesized 
 While all known nucleoside modifications with the exception of queosine are synthesized 
following transcription, the biosynthetic pathways for CoA and NAD-linked RNA have not yet 
been elucidated.  The small molecule that is found on the 5’-end of RNA may be produced 
through the same process as the unlinked cofactor, or there may be a parallel route for 
synthesizing RNA-linked small molecules. 
To determine if the NAD modification on RNA is synthesized through the same pathway 
as the small molecule NAD, we envisioned obtaining a strain requiring nicotinamide for growth 
and then adding isotopically-labeled nicotinamide into the media of the mutant.  If the NAD 
modification on RNA is synthesized through the same biosynthetic pathway as the small 
molecule NAD, the isotope label on the NAD from RNA should be detectable after nuclease 
digestion and LC/MS analysis. 
In E. coli, the small molecule NAD can be synthesized through two different pathways, 
beginning with nicotinamide for the salvage pathway or aspartic acid for the de novo pathway 
(Fig. 4.1).  The E. coli strain with mutant quinolinic acid phosphoribosyl transferase (QAPRT) 
can only synthesize NAD beginning with nicotinamide or nicotinic acid since it cannot convert 
quinolinic acid into nicotinic acid mononucleotide.  QAPRT catalyzes the Mg-dependent transfer 
of the phosphoribosyl moiety from 5-phosphoribosyl-1-pyrophosphate to quinolinic acid, 
yielding nicotinic acid mononucleotide, pyrophosphate and CO2.  This reaction is the third step 
in de novo NAD biosynthesis in all organisms.167 
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Figure 4.1. Biosynthetic pathway of small molecule NAD in E. coli. 
 
 We introduced isotopically-labeled (d4) nicotinic acid into the media of the QAPRT mutant 
(nadC).168  After isolating total RNA, digesting with nuclease and performing LC/MS analysis, a 
peak with one Da less than the expected m/z was observed.  The unlabeled NAD was no longer 
detected.  In parallel, the E. coli mutant was also cultured in media containing h4-nicotinic acid, 
total RNA was isolated and digested with nuclease.  LC/MS analysis revealed the presence of 
unlabeled NAD.  We hypothesize that the labeled nicotinic acid was incorporated into NAD, and 
then a cycle of reduction and oxidation occurred to replace one of the deuteriums with hydrogen 
on the nicotinamide ring (Fig. 4.2).  This would be consistent with the NAD modification being 
synthesized through the same pathway as the small molecule NAD, prior to installation onto 
RNA. 
 
Figure 4.2. Hypothesized redox cycle of isotopically-labeled NAD prior to installation onto 
RNA. 
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4.5 Search for NAD-Binding Proteins and RNA-Binding Proteins That Are Involved in the 
NAD-Linked RNA Pathway 
 Results from the previous experiment to probe the biosynthesis of NAD from the small 
molecule-RNA conjugate indicate that it goes through the same route as the cofactor synthetic 
pathway.  However, the method of installation of NAD onto RNA is not yet known and we 
hypothesize that there is at least one enzyme whose activity is to incorporate the small molecule 
onto the RNA.  To identify proteins that are involved with modulating levels of NAD-linked 
RNA, a screen based on culturing different knockout strains can be conducted.  This screen will 
uncover proteins that affect the synthesis or regulation of NAD-linked RNA. 
Different knockout strains of proteins that are known to bind NAD or RNA were 
obtained.  The individual strains were cultured, total RNA was isolated and digested with 
nuclease and LC/MS analysis was performed to measure levels of NAD modification on RNA.  
If the knockout mutant is of a protein that participates in either the synthesis or installation of the 
NAD modification, a decrease or disappearance of the NAD signal on the LC/MS should be 
observed.  Otherwise, the NAD signal should remain constant.  The extracted ion chromatogram 
signal of NAD was compared with known modifications to account for subtle differences in total 
RNA injected and LC/MS analysis variations. 
Based on gene ontology databases, there are 78 proteins that are annotated as binding 
NAD and 190 proteins that are annotated as binding RNA in E. coli.  None of these proteins have 
been identified as binding both NAD and RNA.  Of the 42 knockout strains we have cultured, 
eight of them have shown a decrease in the NAD signal when compared with total RNA isolated 
from wild type E. coli (Fig. 4.3).  
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Figure 4.3. NAD signal from knockout strains of NAD-binding and RNA-binding proteins are 
decreased in eight strains.  The ratios of NAD to two known nucleotide modifications were 
compared: (a) ms2i6A, a tRNA modification and (b) m26A, a rRNA modification, in wild-type 
and mutant strains. 
 
Seven of the eight strains use NAD or NADH as a cofactor for its activity, while one is a 
predicted rRNA modification enzyme (Fig. 4.4).  To verify that these proteins are indeed 
involved in regulating the level of NAD-linked RNA, complementation assays are ongoing.  The 
gene on a plasmid would be introduced into a background of the knockout strain and cultured.  
After isolating total RNA, digesting with nuclease and analyzing by LC/MS, we will look for 
rescue of the NAD levels.  If the signal from NAD-linked RNA is back to wild-type, the protein 
that was knocked out is likely involved in processing of NAD-RNA.  Further investigation into 
the collection of proteins that are identified as regulating NAD-linked RNA can lead to a model 
for the synthesis and function of the small molecule-RNA conjugate. 
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Strain Annotated Function of Knocked-Out Protein 
JW1658 conserved protein with FAD/NAD(P)-binding domain 
JW2133 NADH-dependent dihydropyrimidine dehydrogenase subunit 
JW2275 NADH:ubiquinone oxidoreductase, membrane subunit J 
JW2276 NADH:ubiquinone oxidoreductase, chain I 
JW2277 NADH:ubiquinone oxidoreductase, membrane subunit H 
JW2301 conserved protein with NAD(P)-binding Rossmann-fold domain 
JW3581 predicted rRNA methylase 
JW5875 NADH:ubiquinone oxidoreductase, chain B 
 
Figure 4.4. Annotated functions of knockout strains 
 NAD-linked RNA levels may be affected by environmental factors, such as temperature, 
pH, nutrients and oxygen levels.  E. coli can be cultured under specific conditions and total RNA 
can be isolated, digested with nuclease and analyzed by LC/MS.  The levels of NAD found can 
yield insight into its biological function since there may be dramatic responses to certain 
conditions.  The response to environmental factors suggests that NAD-linked RNA may be 
involved in those pathways. 
  
4.6 Conclusions  
Given the abundance of the NAD-linked RNA conjugates coupled with the size 
fractionation data, we hypothesized that NAD may be present on individual or a group of tRNAs. 
Biotinylated antisense probes were incubated with cellular RNA and pull-downs were 
performed.  Following nuclease digestion, the fractions from the individual pull-downs were 
analyzed by LC/MS.  The presence of NAD-linked RNA was not detected in the streptavidin 
elution fraction.  However, the expected NAD signal was found in the flow-through fraction, 
suggesting that NAD is not on the 5’ end of individual tRNA.  The antisense probes were also 
combined and used for pull-downs of all of the tRNAs from cellular E. coli RNA.  Again, NAD 
was only detected in the flow-through.  Taken together, the data suggests that NAD is also not 
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present on the group of tRNAs, but rather, is linked to another abundant RNA within the same 
size regime. 
Other species were also cultured and total RNA was extracted to investigate the 
prevalence of the presence of NAD-linked RNA.  The small molecule modification was detected 
in species spanning both the prokaryotic and eukaryotic domains of life.  Applications of the 
nuclease-based screen revealed NAD-linked RNA in B. subtilis, V. fisheri and E. aerogenes, as 
well as in bovine tRNA.  The conservation of the NAD modification suggests that NAD-linked 
RNA has a functional role since it has been evolutionarily preserved. 
 To investigate how the small molecule from NAD-linked RNA was synthesized, labeled 
nicotinic acid was introduced into the media of a strain that requires nicotinic acid for growth.  
After culturing, total RNA was isolated and digested with nuclease.  By LC/MS analysis, the 
presence of a species that was one Da less than the expected m/z was observed.  We 
hypothesized that after the labeled d4-nicotinic acid was incorporated into NAD, a cycle of 
reduction and oxidation occurred to replace one of the deuteriums with hydrogen on the 
nicotinamide.  Therefore, the NAD modification is likely synthesized through the same pathway 
as the small molecule NAD, prior to installation onto RNA. 
 We are also interested in determining the proteins that are involved with NAD-linked 
RNA, either through its biosynthesis, incorporation of the small molecule onto RNA or cellular 
function.  Therefore, the knockout strains of annotated NAD-binding or RNA-binding proteins 
were cultured.  Eight mutants that show decreased levels of NAD compared with known tRNA 
and rRNA modifications have been identified.  We are in the process of performing 
complementation assays to see if these mutants can be rescued.  If so, then the proteins are likely 
candidates that affect the levels of NAD-linked RNA. 
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 A better understanding of the cellular roles of small molecule-RNA conjugates can add to 
the functional diversity of RNA.  Knowing the different proteins that NAD-linked RNA interacts 
with, and the mechanism of interaction can help build a model for the small molecule-RNA 
conjugate’s role.  Further exploration into biological conditions that affect levels of NAD-linked 
RNA may inform roles of the small molecule-RNA conjugate. 
 
4.7 Materials and Methods 
General.  Unless otherwise noted, all starting materials were obtained from commercial 
suppliers and were used without further purification. 
 
Nicotinamide labeling of NAD.  The mutant nadC (Keio collection) was grown to an OD600 = 
0.7-0.8 at 37 ºC in minimal media (per L: 7g K2HPO4, 2g KH2PO4, 0.5g sodium citrate 5H2O, 
0.1g MgSO4 7H2O, 1g (NH)2SO4, 2.5g glucose)168 supplemented with 10-6 M d4-nicotinamide 
(Cambridge Isotopes, Inc.).  Extraction of total RNA was as described previously. 
 
Knockout mutant screening.  Knockout strains were obtained from the Keio Collection (Yale 
University) and cultured to OD600 = 0.7-0.8 at 37 ºC.  Total RNA was isolated and digested with 
nuclease as described previously. 
 
RNA from other species digestion.  E. coli, S. venezuelae, B. subtilis, E. aerogenes, V. fischeri 
were cultured, and total RNA was isolated and digested with nuclease P1 as described 
previously.  Bovine tRNA (Roche Scientific Inc.) was purchased commercially and digested with 
nuclease P1 as described previously. 
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tRNA pull-downs.  We synthesized antisense probes to individual tRNAs that were designed to 
bind to the D-loop 169 and contained a 3’-biotin.  The sequences are listed below. 
Ile-c: 5’ TAT CAG GGG TGC GCT CTA ACC ACC T 3’ 
Trp-c: 5’ TTG GAG ACC GGT GCT CTA CCA ATT 3’ 
Ala1-c: 5’ CTC CTG CGT GCA AAG CAG GCG CTC TCC CA 
Cys1-c: 5’ AGA CGG ATT TGC AAT CCG CTA CAT AAC CGC 
Asp1-c: 5’ ACC CCC TGC GTG ACA GGC AGG TAT TCT AAC CG 
Phe1-c: 5’ AAC ACG GGG ATT TTC AAT CCC CTG CTC TAC CG 
Gly1-c: 5’ TCA TCA GCT TGG AAG GCT GAG GTA ATA GCC A 
His1-c: 5’ ACG ACA ACT GGA ATC ACA ATC CAG GGC TCT A 
Ile2-c: 5’ CGA CCA AGC GAT TAT GAG TCG CCT GCT CTA AC 
Lys1-c: 5’ CGA CCA ATT GAT TAA AAG TCA ACT GCT CTA CC 
Leu1-c: 5’ AGG ACA CTA ACA CCT GAA GCT AGC GCG TCT ACC AAT TC 
Leu2-c: 5’ GCG GCG CCA GAA CCT AAA TCT GGT GCG TCT A 
Leu3-c : 5’ TAC GGT TGA TTT TGA ATC AAC TGC GTC TAC 
Leu4-c: 5’ GGC ACT ACC ACC TCA AGG TAG CGT GTC TAC 
Leu5-c: 5’ CCG AGG GAT TTT AAA TCC CTT GTG TCT AC 
Met1-c: 5’ GAC CCC ATC ATT ATG AGT GAT GTG CTC TAA 
Asn1-c: 5’ CAT ACG GAT TAA CAG TCC GCC GTT CTA CCG 
Pro1-c: 5’ CCA CTG GTC CCA AAC CAG TTG CGC TAC CAA G 
Pro2-c: 5’ CCC TTC GTC CCG AAC GAA GTG CGC TAC CAG G 
Pro3-c: 5’ CCC CGA CAC CCC ATG ACG GTG CGC TAC CAG G 
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Arg1-c: 5’ TCT GCC TCC GGA GGG CAG CGC TCT ATC CAG 
Arg2-c: 5’ CCC ACG ACT TAG AAG GTC GTT GCT CTA TCC 
Arg4-c: 5’ CGC TCG GTT CGT AGC CGA GTA CTC TAT CCA 
Arg5-c: 5’ ATT AGC CCT TAG GAG GGG CTC GTT ATA TCC 
Ser1-c: 5’ CTC CGG TTT TCG AGA CCG GTC CGT TCA GCC 
Ser2-c: 5’ CGC CGG TTT TCA AGA CCG GTG CCT TCA ACC 
Ser4-c: 5’ CAT ACT CCC TTA GCA GGG GAG CGC CTT CAG 
Ser5-c: 5’ CGT ATA CAC ACT TTC CAG GCG TGC TCC TTC 
Thr1-c: 5’ CGC ACC CTT GGT AGG GGT GGG GTC CCC AGT TC 
Thr2-c: 5’ CGC ACC CTT GGT AAG GGT GAG GTC GGC AGT TC 
Thr3-c: 5’ GCA ACT GAC TTG TAA TCA GTA GGT CAC CAG TT 
Thr4-c: 5’ GCA GCG CAT TCG TAA TGC GAA GGT CGT AGG T 
Thr5-c: 5’ GCG CAC CCT TGG TAA GGG TGA GGT CCC CAG T 
Val1-c: 5’ GGG AGA GCA CCT CCC TTA CAA GGA GGG GGT 
Val2-c: 5’ GGT TAG AGC ACC ACC TTG ACA TGG TGG GGG T 
Val3-c: 5’ GCA CCA CCT TGA CAT GGT GGG GGT CGT TGG TT 
A 200 µL suspension of Streptavidin Sepharose High Performance (GE Healthcare) resin 
was poured into the upper cup of an Ultrafree-MC (0.22 mm; Millipore) and equilibrated with 
PBS.  After complete removal of the buffer by centrifugation at 13,200 rpm for 1 min, 400 ml of 
7.5 uM biotinylated oligoDNA solution was mixed with the resin and incubated for 10 min at 
room temperature.  The resin was washed twice with PBS.  500 µL of total RNA was added to 
the resin in 2x hybridization buffer (20 mM Tris–HCl (pH 7.6), 1.8 M tetramethylammonium 
chloride, 0.2 mM EDTA) and incubated at 65 C for 10min.  The columns were cooled to rt and 
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washed six times with 10 mM Tris-HCl, pH 8.  The RNA was resuspended in 200 µL water, and 
eluted from the streptavidin by incubation at 65 C for 10min.  The elution was repeated once. 
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